Next Article in Journal
The Application of Seaweed Polysaccharides and Their Derived Products with Potential for the Treatment of Alzheimer’s Disease
Next Article in Special Issue
Structurally Diverse Polycyclic Salicylaldehyde Derivative Enantiomers from a Marine-Derived Fungus Eurotium sp. SCSIO F452
Previous Article in Journal
Cytoprotective Role of Edible Seahorse (Hippocampus abdominalis)-Derived Peptides in H2O2-Induced Oxidative Stress in Human Umbilical Vein Endothelial Cells
Previous Article in Special Issue
Neuroprotective Metabolites from Vietnamese Marine Derived Fungi of Aspergillus and Penicillium Genera
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Metabolites of Marine Sediment-Derived Fungi: Actual Trends of Biological Activity Studies

by
Anton N. Yurchenko
1,
Elena V. Girich
1 and
Ekaterina A. Yurchenko
2,*
1
Laboratory of Chemistry of Microbial Metabolites, G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch of Russia Academy of Sciences, 690022 Vladivostok, Russia
2
Laboratory of Bioassays and Mechanisms of Action of Biologically Active Substances, G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch of Russia Academy of Sciences, 690022 Vladivostok, Russia
*
Author to whom correspondence should be addressed.
Mar. Drugs 2021, 19(2), 88; https://doi.org/10.3390/md19020088
Submission received: 28 December 2020 / Revised: 22 January 2021 / Accepted: 1 February 2021 / Published: 4 February 2021
(This article belongs to the Special Issue Bioactive Compounds from Marine Sediment Derived Fungi)

Abstract

:
Marine sediments are characterized by intense degradation of sedimenting organic matter in the water column and near surface sediments, combined with characteristically low temperatures and elevated pressures. Fungi are less represented in the microbial communities of sediments than bacteria and archaea and their relationships are competitive. This results in wide variety of secondary metabolites produced by marine sediment-derived fungi both for environmental adaptation and for interspecies interactions. Earlier marine fungal metabolites were investigated mainly for their antibacterial and antifungal activities, but now also as anticancer and cytoprotective drug candidates. This review aims to describe low-molecular-weight secondary metabolites of marine sediment-derived fungi in the context of their biological activity and covers research articles published between January 2016 and November 2020.

Graphical Abstract

1. Introduction

Marine sediments are extreme marine environmental conditions reflecting the condition of sea waters as well as coastal areas. A wide variety of inhabitants of marine sediments makes this ecosystem highly competitive, which affects the metabolism of organisms.
Marine sediments are characterized by intense degradation of sedimenting organic matter in the water column and near surface sediments, resulting in recalcitrant organic matter in subsurface layers, combined with characteristically low temperatures and elevated pressures. For a long time, these geophysical conditions were thought to make this area uninhabitable. The perceived low energy supply coupled with geological time scales resulted in the view that most microorganisms in sub seafloor sediments must be either inactive or adapted for extraordinarily low metabolic activity [1]. The revision of the microbiological methods for studying sediments has led to the modern view that the biomass of marine sediments, including deep-sea sediments, can be very significant and have a serious impact on the geological processes of the ocean bottom [2]. The microbial community of bottom sediments includes bacteria and archaea as well as fungi, but the role of the latter in the marine carbon cycle and other biogeochemical process is not yet clear enough [2].
The few studies devoted to a comprehensive estimation of benthic biodiversity, including both prokaryotic and eukaryotic microorganisms, show that fungi (eukaryotic microorganisms) are less represented in the microbial communities of sediments than bacteria and archaea (prokaryotes). A study of microbial communities of coral reefs in the Gulf of Thailand (the South China Sea) showed that relative abundance of fungi in bottom sediments was only 0.017% (avg.), whereas in coral samples it was 25–96 times more [3].
The diversity of microorganisms, both prokaryotic and eukaryotic, of Stellwagen Bank National Marine Sanctuary in the Gulf of Maine (the Atlantic Ocean, US coastline) has been investigated. The majority of the community was bacterial, with 59 phyla, but also represented were 17 Fungi, 9 Archaea, 18 Animalia, 14 Chromista, 8 Protozoa, and 2 Plantae phyla [4].
Microeukaryotes (fungi) and prokaryotes (bacteria and archaea) are in a permanent interaction inside sediment ecosystems and inevitably influence each other.
Bacteria produce antifungal metabolites to regulate the number of fungi in communities [5]. In turn, fungi release antibacterial compounds in an environment.
The fungus–bacterium symbiont SCSIO F190/B001 was isolated from a marine sediment sample. The 16S rRNA gene sequence showed a high degree of similarity (99%) to the bacterium Alcaligenes faecalis whereas the ITS1-5.8S rDNA-ITS2 sequence showed 96% sequence similarity and 93% query coverage to fungal Spiromastix sp. CBS13827 sequences identifiable by BLASTN. The bacterial symbiont modulates the fungal host to biosynthesize an antimicrobial polyketide spiromarmycin. Spiromarmycin appears to endow upon the symbiont pair a protective/defensive means of warding off competitor organisms, be they prokaryotic or eukaryotic microorganisms [6].
The biosynthetic pathways in marine fungi including marine sediment-derived fungi result in mycotoxins targeting both bacterial and eukaryotic components of bottom sediment communities [7,8,9]. In the past 15 years, marine sediment-derived fungi have been one of the leading sources of new secondary metabolites that exhibit various types of biological activity. However, for a long time, the study of their biological activity has focused almost exclusively on mycotoxins.
In total, 346 compounds have been described from marine sediment-derived fungi from 2005 till 2015. Antiviral and antimicrobial activity (including sortase A and inhibition of some other enzymes) has been reported for 6 and 24 compounds, respectively. Cytotoxic activity together with cancer-preventive activity and indolamino-2,3-dioxygenase activity inhibition was described for 127 metabolites. At the same time, only nine compounds were reported as anti-inflammatory agents, as well as acetylcholinesterase inhibitors and neuritogenic inductors [10,11,12,13].
Few reviews focus on metabolites of marine fungi in general or producers from particular taxa. However, to the best of our knowledge there are no reviews focused on the metabolites of marine sediment-derived fungi.
This review focuses on low-molecular-weight secondary metabolites of marine sediment-derived fungi in the context of their biological activity, and covers research articles published between January 2016 and November 2020.

2. Antiviral Activity

The COVID-19 pandemic that was declared by World Health Organization (WHO) on March 11, 2020 has drawn a lot of attention to drugs with a direct antiviral effect against various viruses, not just molecules that induce antiviral immunity. Despite the increasing spread of antiviral therapy with monoclonal antibodies, the majority of antiviral drugs are low-molecular-weight compounds belonging to various chemical classes. This maintains a stable interest in the study of antiviral properties of the metabolites of marine fungi [14].
The new hydroxamate siderophore-containing cyclopeptides acremonpeptides A–D and known Al(III)−acremonpeptide D (Figure 1) were isolated from the marine fungus Acremonium persicinum SCSIO115 (from the South China Sea). Acremonpeptides A (1) and B (2) and compound 3 have shown moderate antiviral effect against the herpes simplex virus 1 [15].
The xanthone derivatives coniochaetone J (4) and epiremisporine B (5) from Penicillium sp. SCSIO Ind16F01 (the Indian Ocean) exhibited weak activity against enterovirus EV71 in vitro, and 5 also was active against influenza A virus subtype H3N2. Moreover, these metabolites have shown cytotoxic effects on the human erythroleukemia K562, human breast MCF-7, and human gastric carcinoma SGC7901 cancer cell lines [16].
A new class of phenolic lactones spiromastilactones A–M was isolated from a deep-sea derived fungus Spiromastix sp. (south of the Atlantic Ocean). Most of these compounds exert inhibitory activity against WSN influenza virus with low cytotoxicity. Moreover, spiromastilactone D (6), a 5′-chloro-2′-methoxy substituted analogue, displayed the most potential to inhibit a panel of influenza A and B viruses including oseltamivir- and amantadine-resistant strains [17].

3. Antibacterial Activity

Since the isolation of penicillin, the antibacterial activity of metabolites of microfilamentous fungi has been the focus of investigations. Marine fungi are no exception in this sense. From 1998 to 2019, more than 270 compounds with antimicrobial properties were isolated from various marine-derived fungi [18].
A new diphenyl ether, diorcinol K (Figure 2), along with three known compounds, diorcinols D, F and I were isolated from Aspergillus sp. CUGB-F046 strain (the Bohai Sea, China). Diorcinol K (7), D (8) and I (9) displayed significant antibacterial activities against Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) [19].
New prenylxanthones aspergixanthones A–K were isolated from Aspergillus sp. ZA-01 (Bohai Sea). Aspergixanthone H (11) exhibited strong activity against Micrococcus lysodeikticus, while aspergixanthone I (12) showed the strongest activity against Vibrio parahemolyticus, V. anguillarum, and V. alginolyticus. Moreover, aspergixanthone G (10) showed cytotoxicity against the A-549 cell line [20,21].
Four new peptides were isolated from fungi Aspergillus allahabadii and A. ochraceopetaliformis (Jeju Island, Korea). Two compounds (13 and 14) from A. allahabadii were determined to be cyclopentapeptides, while those from A. ochraceopetaliformis were a structurally related cyclodepsihexapeptide (15) and its linear analogue (16). These new compounds exhibited moderate inhibition against the bacterial enzyme sortase A as well as a weak inhibition against isocitrate lyase [22].
Fiscpropionates A–F, new polypropionate derivatives, were isolated from Aspergillus fischeri FS452 (Indian Ocean). Four of them, fiscpropionates 1720, exhibited significant noncompetitive inhibitory activities against Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) [23].
Strong activity against Staphylococcus aureus and E. coli was reported for helvolinic acid (21) and helvolic acid (22) (Figure 3) from Aspergillus fumigatus MF071 (the Bohai Sea). A genomic data analysis revealed the putative biosynthetic gene clusters ftm for fumitremorgins, pso for pseurotins, fga for fumigaclavines, and hel for helvolinic acid. These putative biosynthetic gene clusters fundamentally underpinned the enzymatic and mechanistic function study for the biosynthesis of these compounds [24].
A new sorbicillinoid bisvertinolone (23) from Aspergillus protuberus MUT3638 (Hammerfest fiord, the Barents Sea) display significant activity against S. aureus [25].
New brevianamide diketopiperazines together with known anthraquinones versicolorin B (24) and averufin (25) were isolated from Aspergillus versicolor MF180151 (the Bohai Sea, China). Compounds 24 and 25 showed moderate activities against S. aureus and MRSA [26].
A novel anthraquinone, 2-(dimethoxymethyl)-1-hydroxyanthracene-9,10-dione (26), was isolated from Aspergillus versicolor (West Pacific Ocean) and exhibited strong inhibitory activities against two strains of MRSA. Moreover, this one can inhibit topoisomerase IV and AmpC β-lactamase enzyme activities, shown through molecular docking studies [27].
A new indoloditerpene (27) and fifteen known compounds were isolated from Aspergillus versicolor ZZ761 (Shengsi Island, the East China Sea). Compound 27 showed antimicrobial activities against Escherichia coli and Candida albicans [28].
Five new 20-nor-isopimarane diterpenoids, aspewentins D–H (2832), were isolated from Aspergillus wentii SD-310 (the South China Sea). Compounds 2832 showed inhibitory activity against the aquatic pathogens Edwardsiella tarda, Micrococcus luteus, and human pathogens Pseudomonas aeruginosa, Vibrio harveyi, and V. parahemolyticus. Moreover, compounds 28 and 31 showed activity against the plant pathogen Fusarium graminearum [29].
A new emerixanthone E (33), together with four known emodin derivatives from Emericella sp. (the South China Sea), were isolated and showed moderate antibacterial activities against E. coli, Klebsiella pneumoniae, Staphylococcus aureus, Enterococcus faecalis, Acinetobacter baumannii, and Aeromonas hydrophila [30].
Emerimicin IV (34), a unique fungal peptaibol, was isolated from Emericellopsis minima (Talcahuano Bay, Chile) and showed bacteriostatic activity against clinical isolates of MRSA and vancomycin-resistant Enterococcus faecalis (VRE) [31].
Two new benzoate derivatives, ethyl 3,5-dimethoxy-2-propionylbenzoate (35) and ethyl 3,5-dihydroxy-2-propionylbenzoate, and one new phenylacetate derivative, ethyl 3,5-dimethoxy-2-propionylphenylacetate, were isolated from Engyodontium album (the Pacific Ocean). Compound 35 exhibited inhibitory activities against MRSA and Vibrio vulnificus [32]. Moreover, engyodontiumin A (36), a new benzoic acid derivative, was isolated from this fungal strain and showed moderate antibacterial activity against MRSA, Vibrio vulnificus, V. rotiferianus, and V. campbellii, as well as antifungal activity against Aspergillius niger [33].
Six new thiodiketopiperazine alkaloids, eutypellazines N-S, were isolated from fungus Eutypella sp. MCCC 3A00281 (the South Atlantic Ocean). The eutypellazines P–R (3739) (Figure 4) exhibited moderate inhibitory effects against Staphylococcus aureus and VRE [34].
Eutypellol A (40), the first norsesquiterpenoid of the sequicarene family, as well as eutypellol B (41), a rare 7-methyl oxidized 2-carene derivative, and new 2-(2-hydroxy-4-methylcyclohex-3-enyl)propanoic acid (42), along with eight known terpenoids, were isolated from Eutypella scoparia FS46 (the South China Sea). Compounds 40 and 41 showed a weak antibacterial activity against S. aureus [35].
A new alkaloid, a tris-anhydrotetramer of anthranilic acid (α-aminobenzoic acid), named oxysporizoline (43), from Fusarium oxysporum (Suncheon Bay, South Korea, Korea Strait), showed a weak activity against MRSA and multidrug-resistant S. aureus (MDRSA) [36].
Mycousfurans A (44) and B (45), two new usnic acid congeners, were isolated from Mycosphaerella sp. (Donghae-si, Gangwon-do, South Korea, the Japanese Sea) and showed moderate activity against Kocuria rhizophila and S. aureus [37].
Known 2-[(5-methyl-1,4-dioxan-2-yl)methoxy]ethanol (46), 2-[(2R-hydroxypropanoyl)amino]benzamide (47), 4-hydroxybenzandehyde (48), and 2′,3′-dihydrosorbicillin (49) (Figure 5) were isolated from Penicillium sp. M30 strain (Con Co Island, the South China Sea). Compound 46 showed a strong inhibitory effect against Enterococcus faecalis, whereas both 47 and 48 selectively inhibited Escherichia coli. Moreover, 2′,3′-dihydrosorbicillin (49) potentially inhibited α-glucosidase activity [38].
A new derivative of mycophenolic acid named penicacid D (50) was isolated from Penicillium sp. SCSIO sof101 (the South China Sea). Compound 50 exhibited weak activity against E. coli and Acinetobacter baumannii [39].
Purpuride D (51), a new analogue of drimane-type sesquiterpene lactones conjugated with N-acetyl-l-valine, was isolated from Penicillum sp. ZZ1283 (Karachi, Pakistan, the Arabian Sea). Purpuride D showed activities in inhibiting the growth of MRSA, E. coli and Candida albicans [40].
Four verrucosidin derivatives, penicyrone (52), norpenicyrone (53), methyl norpenicyrone (54), and methyl penicyrone (55) were isolated from the hydrothermal vent sulfur-derived fungus Penicillium sp. Y-50-10 (Kueishantao, Taiwan, the East China Sea). Compounds 52–55 showed moderate activity against Bacillus subtilis [41].
9-Dehydroxysargassopenilline A (56) and 1,2-didehydropeaurantiogriseol E (57) were isolated from Penicillium cyclopium SD-413 (the East China Sea). Compounds inhibited growth of some pathogenic bacteria including Escherichia coli, E. ictaluri, Edwardsiella tarda, Micrococcus luteus, Vibrio anguillarum, and V. harveyi [42].
Tyrosol (58) from Penicillium chrysogenum DXY-1 (Taiwan Strait) was reported as a potential inhibitor of the quorum sensing (QS) systems to solve the looming crisis of bacterial resistance. The compound significantly decreased QS-regulated violacein production in Chromobacterium violaceum CV026 and QS-regulated pyocyanin production, elastase activity, and proteolytic activity in Pseudomonas aeruginosa PA01. Moreover, tyrosol inhibited biofilm formation in P. aeruginosa PA01 without having any effect on bacterial growth [43].
Penijanthines C (59) and D (60) as well as penijanthoids A (61) and B (62), products of Penicillium janthinellum (the Bohai Sea) metabolism, displayed significant activity against three pathogenic Vibrio spp. [44].
Polycyclic quinazoline alkaloid, thielaviazoline was obtained as a result of the microbial transformation of anthranilic acid by Thielavia sp. (Gomso Bay, South Korea, the Yellow Sea). Compound 63 displayed activity against MRSA and MDRSA. Moreover, compound 63 showed potent DPPH radical-scavenging activity [45].
Two new cytochalasans, 16α-methylaspochalasin J (64) and 16-hydroxymethylaspergillin PZ (65), were isolated from Westerdykella dispersa (Guangdong province, China, the South China Sea). Compound 64 exhibited moderate antibacterial activity against Bacillus subtilis, while compound 65 was active against Proteus vulgaris and Enterobacter aerogenes [46].
The salicylaldehyde derivative 66, isolated from Zopfiella marina BCC 18240 (or NBRC 30420, coast of Taiwan), showed moderate activity against Mycobacterium tuberculosis H37Ra and Bacillus cereus [47].

4. Antifungal Activity

Antifungal activity is not rare for metabolites of marine sediment-derived fungi. Presumably, these compounds play a key role in interspecies relationships within fungal communities. Moreover, metabolites that inhibit the growth of aquatic and plant fungal pathogens are of particular importance from a practical point of view.
Two new furandione derivatives, asperfurandiones A (67) and B (68) (Figure 6), were isolated from Aspergillus versicolor (Dongji Island, China, the East China Sea). Both these metabolites showed moderate activity against Gaeumannomyces graminis, Cryptococcus neoformans, and Candida albicans [48].
Novel azaphilone derivatives, named pleosporalone A (69), pleosporalones B (70) and C (71), and pleosporalones E–H, along with three known analogues, were obtained from Pleosporales sp. CF09-1 (the Bohai Sea). Pleosporalone A (69) showed strong activity against plant pathogenic fungi Botrytis cinerea, Rhizopus oryzae and Phytophthora capsici. Pleosporalone B (70) exhibited potent activities against the fungi Alternaria brassicicola and Fusarium oxysporum. Additionally, pleosporalone C (71) displayed significant activity against the fungus Botryosphaeria dothidea [49,50].
Later, a large number of drimane sesquiterpenoids were isolated from this fungal strain and one of them, ustusol A (72), exhibited activity against a panel of plant pathogenic fungi, including Thielaviopsis paradoxa, Pestalotia calabae, and Gloeosporium musarum [51].
Six new alkenylated tetrahydropyran derivatives belonged to polyketides, designated as (12R,13R)-dihydroxylanomycinol (73), (12S,13S)-dihydroxylanomycinol (74), (12R,13S)-dihydroxylanomycinol (75) and (12S,13R)-dihydroxylanomycinol (76), (12S,13R)-N-acetyl-dihydroxylanomycin (77) and (12S,13S)-N-acetyl-dihydroxylanomycin (78), together with one related known compound lanomycinol (79), were isolated from Westerdykella dispersa (the South China Sea). Compounds 7379 exhibited moderate antifungal activities selectively against agricultural pathogenic fungi Rhizoctorzia solani, Verticillium dahliae, Helminthosporium maydis, Fusarium tricinctum, F. oxysporum, Botryosphaeria dothidea, and Alternaria fragriae [52].

5. Plankton Toxicity

The toxicity of metabolites from marine fungi for phyto- and zooplankton organisms is also important for relationships of fungi in marine ecosystems. Nevertheless, the biological activity of compounds from marine sediment-derived fungi is reported as exceedingly rare.
A new sordarin derivative, trichosordarin A (80), with a unique norditerpene aglycone, was isolated from Trichoderma harzianum R5 (the Bohai Sea). Compound 80 (Figure 7) was toxic to Artemia salina, but it appeared to only weakly inhibit Amphidinium carterae and Phaeocystis globosa [53].

6. Cytotoxic Activity

According to the Global Burden of Disease Study project data, total cancers resulted in 23.6 million incident cases, 10 million deaths, and 250 million disability-adjusted life years (DALYs) in 204 countries in 2019. Total cancers were the second-leading cause of death globally in 2019 and this trend has continued since 1990 [54].
As a result, the search for leader antitumor molecules among the metabolites of marine fungi is one of the stable modern trends in chemistry of natural compounds [55,56].
Two new epipolythiodiketopiperazines, named chetracins E (81) and F (82) (Figure 8) were isolated from the fungus Acrostalagmus luteoalbus HDN13-530 (Liaodong Bay, the Bohai Sea). All the compounds exhibited strong cytotoxicity against the five cancer cell lines. The computational docking indicated that compounds 81 and 82 could bind to the C-terminal of heat shock protein 90 (Hsp90), which was in line with the experimental observation of decreases in levels and active forms of Hsp90 client proteins [57].
Waikikiamide A (83), 2,5-diketopiperazine−polyketide hybrid, and waikikiamide C (84), an unprecedented 2,5-diketopiperazine dimer with an N−O−C bridge, were isolated from Aspergillus sp. FM242 (Waikiki beach, Oahu, Honolulu, Hawaii). These showed strong antiproliferative activity against human fibrosarcoma HT1080 line, human prostatic tumor PC3 line, an immortalized T lymphocyte Jurkat line, and human ovarian cancer A2780 cell lines [58].
Asperienes A–D (8689), C-6′/C-7′ epimeric drimane sesquiterpene esters, were isolated from Aspergillus flavus CF13-11 (the Bohai Sea). Compounds 8689 displayed potent activities towards HeLa, MCF-7, MGC-803, and A549 cell lines [59].
Two new drimane sesquiterpenes together with two known derivatives were isolated from Aspergillus flocculosus (Nha Trang Bay, the South China Sea). Compound 90 and its known nitrobenzoyl ester 91 exhibited cytotoxic activity toward human prostate cancer 22Rv1, human breast cancer MCF-7, and murine neuroblastoma Neuro-2a cells [60].
Two new β-bergamotane sesquiterpenoids, E-β-trans-5,8,11-trihydroxybergamot-9-ene and β-trans-2β,5,15-trihydroxybergamot-10-ene, with three known terpenoids, were isolated from Aspergillus fumigatus YK-7 (Yingkou, the Bohai Sea). Known pyripyropene E (92) exhibited potent activity against the human leukemic monocyte lymphoma U937 cell line [61].
A new dimeric naphthopyrone, aurasperone H (93) (Figure 9), was isolated from Aspergillus niger 2HL-M-8 (northeast Brazilian coast, the Atlantic Ocean). Compound 93 exhibited moderate activity against the human lung adenocarcinoma A549 and the human leukemia HL-60 cell lines [62]. Another strain of Aspergillus niger from this location produced a new furoic acid derivative (94) that exhibited cytotoxicity against HCT-116 cell line [63].
A new alkaloid, 17-O-ethylnotoamide M (95), was isolated from a co-culture of marine sediment-derived fungi Aspergillus sulphureus KMM 4640 (East Sakhalin shelf, the Sea of Okhotsk) and Isaria felina KMM 4639 (the South China Sea, coast of Vietnam). Compound 95 inhibited the colony formation of human prostate cancer 22Rv1 cells [64].
New tetranorlabdane diterpenoid asperolide E (96) was isolated from Aspergillus wentii SD-310, a producer of antimicrobial isopimaranes 2832. Asperolide E (96) displayed cytotoxic activities against the HeLa, MCF-7, and lung cancer NCI-H446 cell lines [65].
Three pairs of spirocyclic diketopiperazine enantiomers, variecolortins A and B (97 and 98), were isolated from Eurotium sp. SCSIO F452 (the South China Sea). (+)-97 showed moderate cytotoxicities against SF-268 and HepG2 cell lines, while those of (+)-98 were less active [66].
Two new pimarane-type diterpenes, scopararanes, along with five known ones were isolated from Eutypella sp. FS46 (the South China Sea). Scopararane I (99) showed moderate inhibitory activities against the MCF-7, lung cancer NCI-H460, and SF-268 cell lines [67].
Hypoxone A (100), 4,8-dimethoxy-1-naphthol (101), and 1′-hydroxy-4′,8,8′-trimethoxy[2,2′]binaphthalenyl-1,4-dione (102) were isolated from Hypoxylon rubiginosum FS521 (the South China Sea). Compound 102 exhibited potent cytotoxic activity against SF-268, MCF-7, HepG-2, and A549 tumor cell lines [68].
Unique prostate cancer-toxic polyketides isariketides A (103) and B (104) were isolated from marine sediment-derived fungus Isaria felina (the South China Sea, coast of Vietnam) [69]. Compound 103 exhibited potent cytotoxicity against several lines of human prostate cancer cells, whereas 104 was inactive. Moreover, authors synthesized an acetate derivative of 103 that showed stronger cytotoxicity in comparison with 103.
Eleven compounds including mycophenolic acid and its seven analogues were isolated from Penicillium brevicompactum OUCMDZ-4920 (the South China Sea). Mycophenolic acid (105) (Figure 10) displayed cytotoxicity against murine leukemia P388, human oral epithelial carcinoma KB, human colorectal cancer HT29, human breast cancer MCF-7, and human lung cancer A549 cells [70].
Dicitrinone D (106) as a new polyketide was isolated from Penicillium citrinum (southeast coast of China). Dicitrinone D was safe for normal cells, but effectively inhibited the growth of human lung adenocarcinoma SPC-A1 cells [71].
A new diketopiperazine (107) was isolated from the Antarctic marine-derived fungus Penicillium crustosum HDN153086 (Prydz Bay, the Antarctic Ocean) and exhibited cytotoxicity against K562 cells [72].
New ergostanes, penicisteroids E (108), G (109) and H (110), together with known related penicisteroids A (111) and C (112) were isolated from Penicillium granulatum MCCC 3A00475 (Antarctica). Compounds 108112 showed moderate antiproliferative effects selectively against 12 different cancer cell lines. Compounds 109 and 112, potent RXRa binders with Kd values of 13.8 µM, could induce apoptosis by a retinoid X receptor (RXR)-α-dependent mechanism by regulating RXRα transcriptional expression and promoting the poly-ADP-ribose polymerase (PARP) cleavage. Moreover, they could inhibit proliferation by cell cycle arrest at the G0/G1 phase [73].
The fungus Penicillium janthinellum (Cu Lao Cham Island, the South China Sea) produced new glycosylated alkylresorcinol resorcinoside A (113) (Figure 11) that exhibited cytotoxic activity against the human gastric carcinoma NUGC-3 cell line [74].
New bis-xanthone derivatives, secalonic acids H–M (114119) were isolated from Penicillum oxalicum fungus (Langqi Island, Taiwan Strait). Secalonic acids H (114) and I (115) showed a weak cytotoxic effect toward HCT116, KB, and EC9706 cell lines [75], whereas compounds 116119 exhibited moderate cytotoxicity against HeLa, HCT116, MCF-7, Hep-3B, and A549 cells. Moreover secalonic acid J (116), isolated from Penicillium oxalicum fungus, showed moderate induction of apoptosis in HeLa cells [76].
New halogenated benzophenone derivatives pestalone C (120) and pestalone E (121), were obtained from Pestalotiopsis neglecta (Gagedo Island, the Yellow Sea). Isolated compounds suppressed pancreatic cancer cell line PANC-1 proliferation and induced apoptosis. An in silico study suggested that benzophenone derivatives could potentially inhibit MEK activity by binding to the allosteric pocket in MEK [77].
The marine fungus Phomopsis lithocarpus FS508 (the Indian Ocean) produced a new benzophenone derivative tenellone H (122) that exhibited strong cytotoxic activity against HepG-2 and A549 cell lines [78]. Later, lithocarols A–D (123126) possessing a novel highly-oxygenated isobenzofuran core [79] and lithocarpinols A (127) and B (128), a pair of tenellone diastereoisomers with novel fused skeleton [80], were isolated from this fungal strain. Compounds 123127 displayed a moderate growth inhibitory effect against HepG-2, MCF-7, SF-268, and A549 human tumor cell lines. Interestingly, lithocarpinol B (128) was twice less cytotoxic than its diastereomer 127.
Dipleosporalones A (129) and B (130), two new [2+2] azaphilone dimers (Figure 12), were obtained from Pleosporales sp. (coast of Huanghua, the Bohai Sea). Dipleosporalone A (129) possessed an unprecedented skeleton with an uncommon 6/4/6 ring system. Compounds 129 and 130 showed strong activity against human breast cancer MDA-MB-231 and MCF-7, human gastric cancer MGC-803, cervical cancer HeLa, and human lung epithelial carcinoma A549 cell lines [81].
New anthraquinone derivatives, auxarthrols D–H, together with several known related compounds were obtained from fungus Sporendonema casei (Zhangzi Island, the Yellow Sea). Two of them, auxarthrols D (131) and F (132), showed moderate activities against a few human cancer cell lines. In addition, a weak activity against Mycobacterium phlei, Bacillus subtilis, Vibrio parahemolyticus and Pseudomonas aeruginosa was observed for known altersolanol B (133) [82].
A new sesquiterpenoid 9,10-diolhinokiic acid (134) and a new diterpenoid roussoellol C (135), together with known dankasterone (136), were isolated from Talaromyces purpurogenus (coast of Qinghuangdao, the Bohai Sea). Compound 135 and 136 showed moderate activity toward MCF-7 and HL-60, respectively, whereas 134 possessed only weak cytotoxicity against HL-60 and A549 cells [83].
A number of new cytochalasins together with known analogs and a new tyrosine-derived alkaloid were produced by the fungus Westerdykella dispersa (Guangzhou, China, the South China Sea). Some of them, new 19-methoxy-19,20-dihydrophomacin C (137), alkaloid gymnastatin Z (138), and known phomacin B (139), exhibited moderate activities against MCF-7, HepG2, A549, HT-29, and SGC-7901 human cancer cell lines [84]. One more cytochalasin derivative, named cytochalasin P1 (140), together with known analog 141, were isolated from Xylaria sp. SOF11 (the South China Sea). Compounds 140 and 141 showed significant cytotoxicity against human breast cancer MCF-7 and human glioblastoma SF-268 cells [85].

7. Anti-Inflammatory Activity

Acute and chronic inflammation are the types of cellular response on foreign agent intervention, shock or injury, and hypersensitivity. Inflammation is a necessary response to maintain normal homeostasis in an organism that has been infected or injured. However, prolonged inflammation can cause serious cell and molecule damage which results in different diseases. Normally functioning cells maintain a balance between proinflammatory and anti-inflammatory mediators, and in the event of any action, this balance shifts. The production of proinflammatory mediators during inflammation is promoted by macrophages which include tumor necrosis factor (TNF-a), various interleukins, prostaglandins (PGs), nitric oxide (NO), and reactive oxygen species (ROS) [86]. An increase in the production of these pro-inflammatory mediators is observed in bacterial lipopolysaccharide (LPS)-treated macrophage or microglia cells which are used as inflammation cell models in the search for anti-inflammatory drug candidates. A recent review of anti-inflammatory substances from marine fungi covered the 130 compounds isolated between 2000 and 2018, but did not focus on the source of the fungi [87].
New eremophilane-type sesquiterpenoids acremeremophilanes A-O, together with known analogues, were isolated from Acremonium sp. (south part of the Atlantic Ocean). Acremeremophilanes B–F (142146) and N (147) (Figure 13) exhibited significant inhibitory effects toward NO production in LPS-treated RAW 264.7 macrophage cells [88].
A novel cyclic dipeptide, 14-hydroxy-cyclopeptine (148), was isolated from Aspergillus sp. SCSIOW2 (the South China Sea). Compound 148 inhibited NO production in LPS and recombinant mouse interferon-γ -activated macrophage RAW 264.7 cells [89]. Moreover, three new eremophilane-type sesquiterpenes, dihydrobipolaroxin B (150), dihydrobipolaroxin C (151), and dihydrobipolaroxin D (152), along with one known analogue, dihydrobipolaroxin (149), were isolated from this fungus treated with a combination of histone deacetylase inhibitor (suberohydroxamic acid) and DNA methyltransferase inhibitor (5-azacytidine). Sesquiterpenes 149152 were not produced by the untreated fungal culture. All four compounds exhibited moderate NO inhibitory activities without cytotoxic effects [90].
Three new compounds with novel open-ring butenolide skeletons were isolated from Aspergillus terreus Y10 (coastal area of Hainan, the South China Sea). One of them, asperteretal F (153) was found to dose-dependently inhibit tumor necrosis factor (TNF-α) generation [91].
Asperversiamide G (154) (Figure 14), possessing an unusual pyrano[3,2-f]indole unit, was isolated from Aspergillus versicolor (the South China Sea) and exhibited a potent inhibitory effect against iNO synthase [92].
New phenazine derivatives 155 and 156, along with known saphenic acid derivatives 157160, were isolated from a yeast-like fungus Cystobasidium larynigs (the Indian Ocean). All isolated compounds 155160 showed a nitric oxide (NO) production inhibitory effect in LPS-induced murine macrophage RAW 264.7 cells [93].
A new cadinane sesquiterpene khusinol B (161) isolated from fungus Graphostroma sp. MCCC 3A00421 (the Atlantic Ocean) exhibited significant inhibition of nitric oxide (NO) production in LPS-induced RAW 264.7 macrophages [94].
A marine-derived fungus Penicillium sp. SCSIO sof101, in addition to antimicrobial polyketide 50, produced emodacidamides A, C, D, and E (162165), featuring anthraquinone-amino acid conjugates. Emodacidamides A (162), C (163), D (164), and E (165) inhibited interleukin-2 secretion from Jurkat cells [95].
New meroterpenoid 7-acetoxydehydroaustinol (166) isolated from Penicillium sp. F-5497 (Busan, South Korea, Korean Strait) weakly suppressed NO overproduction in LPS-challenged BV2 microglial cells [96].
Three dimeric nitrophenyl trans-epoxyamides, chrysamides A–C, were obtained from Penicillium chrysogenum SCSIO41001 (the Indian Ocean). Chrysamide C (167) suppressed the production of proinflammatory cytokine interleukin-17 [97].
Several known polyketide metabolites, neuchromenin (168), myxotrichin C (169), and deoxyfunicone (170), were isolated from fungal strain Penicillium glabrum SF-7123 (the Ross Sea, Antarctica). Compounds 168, 169, and 170 (Figure 15) possessed inhibitory activity against production of NO and prostaglandin E2 in LPS-stimulated BV2 microglial and RAW264.7 macrophage cells. The anti-inflammatory effects of 168 were associated with a suppressive effect on iNO synthase and cyclooxygenase-2 activities [98].
Restricticin B (171), a new compound containing a triene, a tetrahydropyran ring, and glycine ester functionalities, together with known N-acetyl restricticin (172), were obtained from fungus Penicillium janthinellum (Cu Lao Cham Island, the South China Sea). Isolated compounds exhibited anti-neuroinflammatory effects in LPS-induced BV-2 microglia cells by suppressing the production of pro-inflammatory mediators [99].
New carotane sesquiterpenoid piltunine E (173) together with several known compounds were isolated from fungus Penicillium piltunense KMM 4668 (Sakhalin Island, the Sea of Okhotsk). New piltunine E (173) and known 5′-hydroxyasperentin (174) significantly downregulated ROS production in LPS-stimulated murine peritoneal macrophages. Moreover, 174 decreased NO production in these cells [100].
A number of new and known curvularin-type macrolides were isolated from fungus Penicillium sumatrense (the Indian Ocean). Only known dehydrocurvularin (175) showed significant inhibition activity towards LPS-induced nitric oxide production in RAW 264.7 macrophages [101].
A known polyketide metabolite citrinin H1 (176) was isolated from fungus Penicillium sp. SF-5629 (Ulgin, South Korea, the Sea of Japan). Citrinin H1 (176) inhibited NO and prostaglandin E2 production in lipopolysaccharide (LPS)-stimulated BV2 microglia cells. Moreover, it was found to suppress cyclooxygenase-2 gene expression and the phosphorylation of inhibitor kappa B-α, to interrupt the nuclear translocation of nuclear factor kappa B, and to decrease the activation of p38 mitogen-activated protein kinase [102].

8. Radical Scavenging and Antioxidant Activities

Imbalance between the pro-oxidant and the antioxidant components of homeostatic systems, i.e., oxidative stress, results in different cellular pathological processes and diseases including diabetes, neurodegeneration, cardiovascular diseases, and others. Primary antioxidants scavenge radical species, converting them into more stable radicals or non-radical species. Secondary antioxidants quench singlet oxygen, decompose peroxides, chelate pro-oxidative metal ions, and inhibit oxidative enzymes. Moreover, four reactivity-based lines of defense have been identified: preventative antioxidants, radical scavengers, repair antioxidants, and those relying on adaptation mechanisms [103].
A new chromone derivative arthone C (177) (Figure 16) was isolated from Arthrinium sp. UJNMF0008 (the South China Sea) and exhibited potent DPPH- and ABTS-radical scavenging activities [104].
A new brominated naphthopyranone 6,9-dibromoflavasperone (178) and three known naphtho-c-pyranone monomers, flavasperone (179), TMC-256A1 (180), and fonsecin (181), and one naphtho-c-pyranone dimer aurasperone B (182), were isolated from Aspergillus niger (Suncheon Bay, South Korea, Korean Strait) fermented with metal bromides (NaBr and CaBr2). Compounds 178182 displayed potent DPPH-radical scavenging activity [105].
A number of xanthones and anthraquinones (183194), including a new xanthone, oxisterigmatocystin D (183), were isolated from Aspergillus versicolor (the South China Sea). The isolated xanthones and anthraquinones (Figure 17) showed moderate antioxidant activities in trolox-equivalent antioxidant capacity (TEAC) assay. A Nrf2-dependent luciferase reporter gene assay revealed that compound 188, averantin (189), averythrin (191), and nidurufin (194) potentially activated the expression of a Nrf2-regulated gene [106].
A new citrinin derivative, cladosporin D (195), isolated from fungus Cladosporium sp. SCSIO z015 (Okinawa Trough, the East China Sea), showed significant DPPH radical scavenging activity [107].
Three new prenylated indole 2,5-diketopiperazine alkaloids (196198) were isolated from fungus Eurotium sp. SCSIO F452 (the South China Sea). Compound 198 showed significant DPPH-radical scavenging activities. Compounds 196 and 197 exhibited moderate antioxidative activities [108]. Further investigation of this fungal strain led to the isolation of several new spirocyclic indolediketopiperazine alkaloid enantiomers, eurotinoids A–C (199204), as well as a known biogenetically related racemate dihydrocryptoechinulin D (205/206). The isolated compounds showed significant DPPH-radical scavenging activities. In addition, (+)-dihydrocryptoechinulin D (205) showed moderate cytotoxicity against SF-268 and HepG2 cell lines [109].
One more study of this fungus, carried out using scaling-up cultivation, resulted in obtaining new salicylaldehyde derivative enantiomers, (+) and (–)-euroticins B (207 and 208). The isolated compounds represent the first example of 6/6/6/6 tetracyclic salicylaldehyde derivatives and exhibited remarkable antioxidative activities [110].
A new auroglaucin-derived compound, niveoglaucin A (209), together with known related compound flavoglaucin (210), as well as indolediketopiperazine alkaloids (±)-cryptoechinulines B (211212), neoechinulin (213), and neoechinulines B–C (214215) (Figure 18), were isolated from fungus Aspergillus niveoglaucus (Nha Trang Bay, the South China Sea). All these compounds suppressed the hyperproduction of ROS in toxins-treated murine neuroblastoma Neuro-2a cells. Moreover, niveoglaucin A (209) and flavoglaucin (210) increased viability of 6-hydroxydopamine (6-OHDA)-treated Neuro-2a cells. (+)-Cryptoechinuline B (211) exhibited neuroprotective activity on 6-OHDA-, paraquat-, and rotenone-induced the cells. (−)-Cryptoechinuline B (212) and neoechinulin C (215) protected the Neuro-2a cells against paraquat toxicity. Neoechinulin B (214) exhibited cytoprotective activity against rotenone toxicity, and neoechinulin (213) showed activity against 6-OHDA [111,112].

9. Influence on Protein Activity and Expression

Different proteins are molecular targets in the search for promising drug molecules.
Researchers of anticancer candidates are focusing on proteins involved in cell cycle control and tumor growth as well as metastasis, apoptosis, and others. Bromodomain-containing protein (BRD4) is the most extensively and thoroughly studied member of bromodomain and the extra-terminal domain family. BRD4 plays an important role in cell cycle control and can affect the processes of cell proliferation, apoptosis, and transcription. In addition to its role in tumors, BRD4 also plays an important role in inflammation, cardiovascular diseases, and viral infections [113]. Glycogen synthase kinase-3 (Gsk-3) is a conserved serine/threonine kinase that mainly participates in cell proliferation, development, stress, and inflammation in humans. Accumulating evidence has suggested that GSK 3 beta is correlated with tumorigenesis and progression. However, GSK 3 beta is controversial due to its bifacial roles of tumor suppression and activation. In addition, overexpression of GSK 3 beta is involved in tumor growth, and it contributes to cell sensitivity to chemotherapy [114]. Moreover, it was reported that Gsk-3 protein can be activated in SARS-CoV-2 viral infected cells which results in excessive oxidative stress via degradation of the nuclear factor erythroid 2-related factor (Nrf2) protein. Activated Gsk-3 also modulates CREB-DNA activity, phosphorylates NF-kappa B, and degrades beta-catenin, thus provoking systemic inflammation [115].
The prevalence of diabetes mellitus, especially type 2, has increased significantly by nearly 40% globally in the past 10 years (http://www.healthdata.org/results/gbd_summaries/2019/diabetes-mellitus-level-3-cause, accessed on 25 December 2020). Various enzymes are considered as therapeutic targets for treating this socially significant disease. Alpha-glucosidase is a family of enzymes originating from the pancreas which play a role in the anabolism of 80–90% of carbohydrates consumed into glucose. Inhibition of these enzymes helps to prevent postprandial hyperglycemia and the formation of glycated end products [116]. Protein-tyrosine phosphatase 1B (PTP1B) negatively regulates insulin signaling pathways and plays an important role in type 2 diabetes mellitus (T2DM), as its overexpression may induce insulin resistance [117].
The acetylcholinesterase enzyme (AChE) is the key enzyme in the hydrolysis of the neurotransmitter acetylcholine and is the target of most of the clinically used drugs for the treatment of Alzheimer’s disease [118].
Sterol O-acyltransferase (SOAT) is an endoplasmic reticulum resident, multitrans membrane enzyme that belongs to the membrane-bound O-acyltransferase (MBOAT) family. It catalyzes the esterification of cholesterol to generate cholesteryl esters for cholesterol storage. In addition to cholesterol, SOAT can use multiple sterols as substrates and activators. Because of its functional importance, SOAT is a potential drug target for Alzheimer’s disease, atherosclerosis, and several types of cancers [119].
The heat shock proteins (Hsps), also named “housekeeping” proteins, constitute a large family of molecular chaperones. Their functions focus on protein folding and refolding and other mechanisms of cytoprotecting. Overexpression of Hsps enhances tolerance of cells to stress factors and increases its viability but it is good only for non-malignant cells, for example in the case of neurodegenerative diseases. In cancer cells, Hsps overexpression results in its higher resistance to drug and radiation anticancer therapy. Thus, Hsps (especially Hsp70) are molecular targets for anticancer (Hsps inhibitors) [120] and cytoprotective (Hsps enhancers) [121] drugs.
A new perylenequinone (216) (Figure 19) isolated from fungus Alternaria sp. NH-F6 (the South China Sea) exhibited a potent bromodomain-containing protein BRD4 inhibition [122].
A new diketopiperazine-like compound, designated protuboxepin K (217), was isolated together with the known structurally related protuboxepin A (218) from Aspergillus sp. BFM-0085 (Tokyo Bay, Tokyo, Japan). Compounds 217 and 218 inhibited bone morphogenetic protein (BMP)-induced alkaline phosphatase activity [123].
Three new butenolide derivatives, flavipesolides A–C (219221), along with known compounds (222227), were isolated from fungus Aspergillus flavipes HN4-13 (the Yellow Sea). Known compounds 222224 and 226 were reported as noncompetitive α-glucosidase inhibitors, whereas new flavipesolides A–C (219221) and known 225 and 227 were described as mixed α-glucosidase inhibitors [124].
A new merosesquiterpenoid asperversin G (228) (Figure 20) obtained from fungus Aspergillus versicolor (the South China Sea) exhibited moderate inhibitory activity against the acetylcholinesterase enzyme (AChE) [125].
A new depsidone, named 7-chlorofolipastatin (229), was isolated from Aspergillus ungui (Suruga Bay, Japan). 7-Chlorofolipastatin inhibited sterol O-acyltransferase (SOAT) 1 and 2 isozymes in cell-based and enzyme assays using SOAT1- and SOAT2-expressing Chinese hamster ovary (CHO) cells [126].
A new isopyrrolonaphthoquinone biscogniauxone (230) and cyclo-(l-Phe-l-Leu-l-Val-l-Leu-l-Leu) (231) were isolated from Biscogniauxia mediterranea (Herodotes Deep, the Mediterranean Sea) and showed inhibitory activity against glycogen synthase kinase (GSK-3β) [127].
New preaustinoid-related meroterpenoid, preaustinoid A6 (232) and known berkeleyone C (233) were isolated from fungus Penicillium sp. SF-5497 (Gijang-gun, Busan, South Korea, Korean Strait) and inhibited PTP1B activity in a dose-dependent manner [128].
A new furanone derivative, butanolide A (234), was isolated from the fungus Penicillium sp. S-1-18 (Antarctica). Compound 234 showed moderate inhibitory activity against PTP1B [129].
New meroterpenoids, austalides V−X, were isolated from Penicillium rudallense (Ga-geo Island, South Korea, the Yellow Sea). Among them, austalides V (235) and W (236) exhibited potent inhibitory activity on the receptor activator of nuclear factor κB ligand (RANKL)-induced osteoclast differentiation [130].
New diorcinol J (237) and known diorcinol B (238) was obtained from the EtOAc extract of a co-culture of marine isolates of the fungi Aspergillus sulphureus KMM 4640 (the Sea of Okhotsk) and Isaria felina KMM 4639 (the South China Sea). The isolated compounds exhibited a weak hemolytic activity and cytotoxicity toward murine Ehrlich carcinoma cells. Moreover, known diorcinol B (238) was able to enhance expression of heat shock protein Hsp70 in Ehrlich ascites carcinoma cells [131].

10. Other Activities

Two new sesterterpenoids, terretonins H (239) and I (240), were isolated from Aspergillus ustus KMM 4664 (the Sea of Okhotsk). Compounds (Figure 21) inhibited the ability of spermatozoa to fertilize egg cells of the sea urchin Strongilocentrotus intermedius [132].
New phenalenone derivatives ent-peniciherqueinone (241) and 4-hydroxysclerodin (242), along with known compounds (243244) of the herqueinone class, were isolated from Penicillium sp. (Gagudo, South Korea) [133]. 4-Hydroxysclerodin (242) exhibited moderate anti-angiogenetic and anti-inflammatory activities. Compound 243 moderately inhibited NO production in RAW 264.7 cells with an IC50 value of 3.2 μM, while the rest of the isolated compounds were inactive (IC50 > 20 μM). In the angiogenesis assay, 242 inhibited tube formation in HUVECs with an IC50 of 20.9 μM, while ent-peniciherqueinone (241) and isoherqueinone (244) induced adipogenesis through PPAR binding and adiponectin secretion-promoting activity in hBM-MSCs and in a concentration-dependent manner, which was determined by adiponectin secretion-promoting effects with their IC50 values of 57.5 μM and 39.7 μM, respectively.
A novel spiro-tetracyclic diterpene, spirograterpene A (245), was isolated from fungus Penicillium granulatum MCCC 3A00475, that also produced cytotoxic ergostanes 108112. The isolated compound showed modest antiallergic activity [134].
A new phenylspirodrimane derivative, stachybotrysin (246), was isolated from fungus Stachybotrys sp. KCB13F013 (Wi Island, South Korea, the Yellow Sea). Stachybotrysin exhibited an inhibitory effect on osteoclast differentiation in bone marrow macrophage cells via suppressing the RANKL-induced activation of p-ERK, p-JNK, p-p38, c-Fos, and NFATc1 [135].

11. Concluding Remarks

Marine sediment-derived fungi are exposed to both natural stress factors, to which adaptive mechanisms have already been developed during evolution, and modern challenges, namely the effect of high concentrations of xenobiotics entering sea water because of pollution and settling to the bottom.
Melanization of hyphae is one of the protection mechanisms against changes in osmotic pressure. Thus, adding tricyclazole, a specific inhibitor of the dihydroxynaphthalene (DHN) type of melanin, in Cirrenalia pygmea growth medium resulted in producing light-colored hyphae which were highly susceptible to osmotic shock [136].
Changes in secondary metabolite production is a strategy for intracellular osmoregulation. Increasing salinity increased the activity of polyol enzymes such as polyol dehydrogenase and mannitol dehydrogenase and, finally, polyols content. Higher salinity also led to an increase in the amino acid pool size as well as glycogen and sterols. Moreover, higher salinity brought about a decrease in the extent of unsaturation of fatty acids. A hypo-osmotic shock resulted in a decrease in the polyol content [137].
Melanin and its related compounds are able to tolerate marine-derived fungi oxidative stress inducing UV radiation and xenobiotics. The isolation of melanin biosynthesis intermediates from marine-derived fungus and finding their antioxidant and cytoprotective activities confirms the role of them in cell protective machinery [138].
Dihydroxynaphthalene (DHN) melanin pathway is a basic melanin formation in fungi [139] and it is a special case of polyketide pathways which result in a big structural variety of polyketide metabolites [140].
In total, 246 compounds with various biological activities were reported from 2016 to November 2020 (Appendix A Table A1). In terms of chemical structures, most of them belong to polyketides (54%), and alkaloids (21%) and terpenoids (17%) combined are the second most common. The rarest bioactive compounds are peptides (4%) and meroterpenoids (4%) (Figure 22a).
Antiviral activity against various subtypes of influenza virus and herpes simplex virus 1 has been reported for 12 compounds. For a number of reasons, an investigation of antiviral activity is one of the most difficult bioassays and this is a limiting factor for the discovery of new antiviral drug candidates. Nevertheless, the studying of secondary metabolites from marine sediment-derived fungi for their antiviral activity is promising. The COVID-19 pandemic showed humanity’s vulnerability, but advances in this field, e.g., anti-HIV therapy, offer hope.
Antibacterial activity has been reported for 57 compounds from marine sediment-derived fungi. With the aim of helping to prioritize the research and development of new and effective antibiotic treatments, the WHO recently published a list of bacterial pathogens for which new antibiotics are urgently needed at a global level [141]. Priority I (critical) comprises carbapenem-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and members of Enterobacteriaceae, that is, Klebsiella pneumoniae, Escherichia coli, Enterobacter spp., Serratia spp., Proteus spp., Providencia spp., and Morganella spp. Representatives of the group Priority II (high) are vancomycin-resistant Enterococcus faecium and methicillin- and/or vancomycin-resistant Staphylococcus aureus. Penicillin-non-susceptible Streptococcus pneumoniae, among others, belongs to Priority III (medium).
In this regard, such marine sediment-derived fungal metabolites as 2-(dimethoxymethyl)-1-hydroxyanthracene-9,10-dione (26), emerixanthone E (33), emerimicin IV (34), penicacid D (50), and tyrosol (58), which show significant activity against one or more these bacterial pathogens, may be of particular interest for further research.
Cytotoxic activity against various cancer line cells was reported for 62 compounds isolated from marine sediment-derived fungi.
Many natural and semi-synthetic compounds with various antitumor effects are published annually. At first glance, this does not seem to lead to the desired success in new low-molecular-weight drug development. At this time there is only one successful drug candidate for anticancer therapy among marine fungal metabolites. It is plinabulin, a synthetic derivative of phenylahistine (from algicolous Aspergillus ustus), that is under Phase II and III of clinical trials in complex therapy of various cancers [142]. From 2005 to 2015, cytotoxic activity was reported for 37% of isolated bioactive fungal metabolites (Introduction section) and from 2016 to 2020 it was reported only for 25% of the compounds (Figure 22b).
More than 70 secondary metabolites with various cytoprotective properties have been isolated from marine sediment-derived fungi from 2016 to now. Anti-inflammatory activity was described for 33 compounds. Radical scavenging and antioxidant activities were reported for 37 compounds and for 7 from them a neuroprotective effect was shown. Moreover, enhancing of Hsp70 expression was reported for one compound.
As was noted in the Introduction, only nine compounds with cytoprotective properties have been identified from 2005 to 2015. Of course, it should be borne in mind that the biological activity could have been studied and published later, but a change in the trend in the study of the biological effects of compounds is clearly visible.
It is obvious that further development of the field of marine fungal metabolites investigation will be determined by improvements of the existing isolation and identification techniques, as well as by the arrival of fundamentally new approaches. Moreover, at present, there is an increasing interest in studies of the fungal metabolome that give perspectives in complex estimation of biosynthetic abilities of fungal strains and the influence of ecological factors on fungal metabolomes. Using gene cluster technologies together with the metabolome approach will allow controlling of the fungal biosynthetic pathways to obtain metabolites with the expected biological properties.

Author Contributions

Conceptualization, A.N.Y. and E.A.Y.; Data Curation, A.N.Y. and E.A.Y.; Writing—Original Draft Preparation, A.N.Y., E.V.G. and E.A.Y.; Visualization, E.V.G.; Writing—Review and Editing, A.N.Y. and E.A.Y.; Supervision, E.A.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by Russian Science Foundation (grant 19-74-10014).

Acknowledgments

The authors dedicate this review to the memory of Shamil Afiyatullov, who made a great contribution to the study of marine fungal metabolites of the Pacific region. The authors thank Sophia Kolesnikova (G.B. Elyakov Pacific Institute of Bioorganic Chemistry) for the valuable comments.

Conflicts of Interest

The authors declare no conflict of interest.

Appendix A

Table A1. Bioactive compounds from marine sediment-derived fungi from 2016 to 2020.
Table A1. Bioactive compounds from marine sediment-derived fungi from 2016 to 2020.
CompoundFungusIsolation placeActivityRef.
Acremonpeptide A (1)Acremonium persicinum SCSIO115The South China SeaAntiviral (herpes simplex virus 1)[15]
Acremonpeptide B (2)
Al(III)—acremonpeptide D (3)
Coniochaetone J (4)Penicillium sp. SCSIO Ind16F01The Indian OceanAntiviral (enterovirus EV71),
Cytotoxic (K562, MCF-7, SGC7901)
[16]
Epiremisporine B (5) Antiviral (enterovirus EV71, influenza A virus subtype H3N2), Cytotoxic (K562, MCF-7, SGC7901)
Spiromastilactone D (6)Spiromastix sp. South of The Atlantic OceanAntiviral (a panel of influenza A and B viruses)[17]
Diorcinol K (7) Aspergillus sp. CUGB-F046 The Bohai Sea, ChinaAntibacterial (SA, MRSA)[19]
Diorcinol D (8)
Diorcinol I (9)
Aspergixanthone H (11)Aspergillus sp. ZA-01 The Bohai SeaAntibacterial (Micrococcus lysodeikticus)[20,21]
Aspergixanthone I (12) Antibacterial (Vibrio parahemolyticus, V. anguillarum, and V. alginolyticus)
Aspergixanthone G (10)
JG002CPA (13) Aspergillus allahabadiiJeju Island, KoreaCytotoxic (A-549)[22]
JG002CPB (14)
FJ120DPA (15) Aspergillus ochraceopetaliformis
FJ120DPB (16)
Fiscpropionates A–D (1720)Aspergillus fischeri FS452 Indian OceanAntibacterial (Mycobacterium tuberculosis protein tyrosine phosphatase B inhibition)[23]
Helvolinic acid (21)Aspergillus fumigatus MF071 The Bohai SeaAntibacterial (SA, E. coli)[24]
Helvolic acid (22)
Bisvertinolone (23)Aspergillus protuberus MUT3638 Hammerfest fiord, The Barents SeaAntibacterial (SA)[25]
Versicolorin B (24)Aspergillus versicolor MF180151 The Bohai SeaAntibacterial (SA, MRSA)[26]
Averufin (25)
2-(Dimethoxymethyl)-1-hydroxyanthracene-9,10-dione (26)Aspergillus versicolorWest Pacific OceanAntibacterial (MRSA), inhibition of topoisomerase IV and AmpC β-lactamase enzymes activity[27]
(3R,9S,12R,13S,17S,18S)-2-carbonyl-3-hydroxylemeniveol (27)Aspergillus versicolor ZZ761 Shengsi Island, The East China SeaAntibacterial and antifungal (E. coli and Candida albicans)[28]
Aspewentins D–H (2832)Aspergillus wentii SD-310 The South China SeaAntibacterial (Edwardsiella tarda, Micrococcus luteus, Pseudomonas aeruginosa, Vibrio harveyi, and V. parahemolyticus), antifungal (Fusarium graminearum)[29]
Emerixanthone E (33)Emericella sp. The South China SeaAntibacterial (SA, E. coli, Klebsiella pneumoniae, Enterococcus faecalis, Acinetobacter baumannii, Aeromonas hydrophila)[30]
Emerimicin IV (34)Emericellopsis minimaTalcahuano Bay, ChileBacteriostatic (MRSA, VRE)[31]
Ethyl 3,5-dimethoxy-2-propionylbenzoate (35)Engyodontium albumThe Pacific OceanAntibacterial (MRSA and Vibrio vulnificus)[32]
Engyodontiumin A (36) Antibacterial (MRSA, Vibrio vulnificus, V. rotiferianus, and V. campbellii), antifungal (Aspergillus niger)[33]
Eutypellazines P–R (3739)Eutypella sp. MCCC 3A00281 The South Atlantic OceanAntibacterial (SA, VRE)[34]
Eutypellol A (40)Eutypella scoparia FS46 The South China SeaAntibacterial (SA)[35]
Eutypellol B (41)
2-(2-Hydroxy-4-methylcyclohex-3-enyl)propanoic acid (42)
Oxysporizoline (43)Fusarium oxysporumSuncheon Bay, South Korea, Korea StraitAntibacterial (MRSA, MDRSA)[36]
Mycousfuran A (44) Mycosphaerella sp. Donghae-si, Gangwon-do, South Korea, The Japanese SeaAntibacterial (Kocuria rhizophila and SA)[37]
Mycousfuran B (45)
2-[(5-Methyl-1,4-dioxan-2-yl)methoxy]ethanol (46)Penicillium sp. M30 Con Co Island, The South China SeaAntibacterial (Enterococcus faecalis)[38]
2-[(2R-Hydroxypropanoyl)amino]benzamide (47) Antibacterial (E. coli)
4-Hydroxybenzandehyde (48)
2′,3′-Dihydrosorbicillin (49) Inhibition of α-glucosidase activity
Penicacid D (50)Penicillium sp. SCSIO sof101 The South China SeaAntibacterial (E. coli and Acinetobacter baumannii)[39]
Purpuride D (51)Penicillum sp. ZZ1283 Karachi, Pakistan, The Arabian SeaAntibacterial (MRSA, E. coli), antifungal (Candida albicans)[40]
Penicyrone (52)Penicillium sp. Y-50-10 Kueishantao, Taiwan, The East China SeaAntibacterial (Bacillus subtilis)[41]
Norpenicyrone (53)
Methyl norpenicyrone (54)
Methyl penicyrone (55)
9-Dehydroxysargassopenilline A (56)Penicillium cyclopium SD-413 The East China SeaAntibacterial (E. coli, E. ictaluri, Edwardsiella tarda, Micrococcus luteus, Vibrio anguillarum, and V. harveyi)[42]
1,2-Didehydropeaurantiogriseol E (57)
Tyrosol (58)Penicillium chrysogenum DXY-1 Taiwan StraitAntibacterial (inhibitor of the quorum sensing (QS) system in Chromobacterium violaceum andPseudomonas aeruginosa,
biofilm formation in P. aeruginosa)
[43]
Penijanthines C (59)Penicillium janthinellumThe Bohai SeaAntibacterial (Vibrio spp.)[44]
Penijanthine D (60)
Penijanthoid A (61)
Penijanthoid B (62)
Thielaviazoline (63)Thielavia sp. Gomso Bay, The Yellow SeaAntibacterial (MRSA, MDRSA)
DPPH radical-scavenging
[45]
16α-Methylaspochalasin J (64)Westerdykella dispersaThe South China SeaAntibacterial (Bacillus subtilis)[46]
16-Hydroxymethylaspergillin PZ (65) Antibacterial (Proteus vulgaris, Enterobacter aerogenes)
2-Hydroxy-6-((1E,3E)-7-hydroxyundeca-1,3-dienyl)benzaldehyde (66)Zopfiella marina BCC 18240 (or NBRC 30420)coast of TaiwanAntibacterial (Mycobacterium tuberculosis H37Ra, Bacillus cereus)[47]
Asperfurandione A (67)Aspergillus versicolorDongji Island, The East China SeaAntifungal (Gaeumannomyces graminis, Cryptococcus neoformans, Candida albicans)[48]
Asperfurandione B (68)
Pleosporalone A (69), Pleosporales sp. CF09-1 The Bohai SeaAntigungal (Botrytis cinerea, Rhizopus oryzae, Phytophthora capsica)[49,50]
Pleosporalone B (70) Antifungal (Alternaria brassicicola, Fusarium oxysporum)
Pleosporalone C (71) Antifungal (Botryosphaeria dothidea)
Ustusol A (72) Antifungal (Thielaviopsis paradoxa, Pestalotia calabae, and Gloeosporium musarum)[51]
12R,13R)-Dihydroxylanomycinol (73), Westerdykella dispersaThe South China SeaAntifungal (Rhizoctorzia solani, Verticillium dahliae, Helminthosporium maydis, Fusarium tricinctum, F. oxysporum, Botryosphaeria dothidea, and Alternaria fragriae)[52]
(12S,13S)-Dihydroxylanomycinol (74)
(12R,13S)-Dihydroxylanomycinol (75)
(12S,13R)-Dihydroxylanomycinol (76)
(12S,13R)-N-Acetyl-dihydroxylanomycin (77)
(12S,13S)-N-Acetyl-dihydroxylanomycin (78)
Lanomycinol (79)
Trichosordarin A (80)Trichoderma harzianum R5 The Bohai SeaToxicity for plankton (Artemia salina, Amphidinium carterae and Phaeocystis globose)
Chetracin E (81) Acrostalagmus luteoalbus HDN13-530 Liaodong Bay, The Bohai SeaCytotoxicity, Inhibition of Hsp90[57]
Chetracin F (82)
Waikikiamide A (83)Aspergillus sp. FM242 Waikiki beach, Oahu, Honolulu, HawaiiAntiproliferative activity (HT1080, PC3, Jurkat, A2780 line cells)[58]
Waikikiamide C (84)
Asperienes A–D (8689)Aspergillus flavus CF13-11 The Bohai SeaCytotoxicity (HeLa, MCF-7, MGC-803 and A549 cell lines)[59]
6β,9α,14-Trihydroxycinnamolide (90)Aspergillus flocculosusNha Trang Bay, The South China SeaCytotoxicity (22Rv1, MCF-7, Neuro-2a)[60]
Insulicolide A (91)
Pyripyropene E (92)Aspergillus fumigatus YK-7 Yingkou, The Bohai SeaCytotoxicity (U937 cell line)[61]
Aurasperone H (93)Aspergillus niger 2HL-M-8 Northeast Brazilian coast, The Atlantic OceanCytotoxicity (A549, HL-60)[62]
Methyl 5-(1-acetamido-2-phenylethyl)furan-2-carboxylate (94)Aspergillus nigerNortheast Brazilian coast, The Atlantic OceanCytotoxicity (HCT-116)[63]
17-O-ethylnotoamide M (95)Aspergillus sulphureus KMM 4640 and
Isaria felina KMM 4639
East Sakhalin shelf, The Sea of OkhotskThe South China Sea, coast of VietnamInhibition of the colony formation (22Rv1 cells)[64]
Asperolide E (96)Aspergillus wentii SD-310The South China SeaCytotoxicity (HeLa, MCF-7, NCI-H446 line cells)[65]
Variecolortin A (97)Eurotium sp. SCSIO F452 The South China SeaCytotoxicity (SF-268, HepG2 cell lines)[66]
Variecolortin B (98)
Scopararane I (99)Eutypella sp. FS46 The South China SeaCytotoxicity (MCF-7, NCI-H460, SF-268)
-
-
[67]
Hypoxone A (100) Hypoxylon rubiginosum FS521 The South China Sea
4,8-Dimethoxy-1-naphthol (101)
1’-Hydroxy-4’,8,8’-trimethoxy[2,2’]binaphthalenyl-1,4-dione (102) Cytotoxicity (SF-268, MCF-7, HepG-2, and A549)[68]
Isariketide A (103) Isaria felinaThe South China Sea, coast of VietnamCytotoxicity (human prostate cancer cells)
-
[69]
Isariketide B (104)
Mycophenolic acid (105)Penicillium brevicompactum OUCMDZ-4920 The South China SeaCytotoxicity (P388, KB, HT29, MCF-7, A549)[70]
Dicitrinone D (106)Penicillium citrinumSoutheast coast of ChinaCytotoxicity (SPC-A1)[71]
Fusaperazine F (107)Penicillium crustosum HDN153086 Prydz Bay, The Antarctic OceanCytotoxicity (K562)[72]
Penicisteroid E (108) Penicillium granulatum MCCC 3A00475 AntarcticaAntiproliferative effect (12 cancer cell lines)s[73]
Penicisteroid G (109)
Penicisteroid H (110)
Penicisteroid A (111)
Penicisteroid C (112)
Resorcinoside A (113)Penicillium janthinellumCu Lao Cham Island, The South China SeaCytotoxicity (NUGC-3)[74]
Secalonic acid H (114)Penicillum oxalicum fungus (Langqi Island, Taiwan Strait) Cytotoxicity (HCT116, KB, EC9706)[75]
Secalonic acid I (115) [75]
Secalonic acid J (116) Cytotoxicity (HeLa, HCT116, MCF-7, Hep-3B, A549) [76]
Secalonic acid K (117)
Secalonic acid L (118)
Secalonic acid M (119)
Pestalone C (120)
Pestalone E (121)
Pestalotiopsis neglectaGagedo Island, The Yellow SeaAntiproliferative and apoptotic activity (PANC-1)[77]
Tenellone H (122)Phomopsis lithocarpus FS508 The Indian OceanCytotoxicity (HepG-2, A549)[78]
Lithocarols A–D (123126) Cytotoxicity (HepG-2, MCF-7, SF-268, and A549)[79]
Lithocarpinols A (127) and B (128) [80]
Dipleosporalones A (129) and B (130)Pleosporales sp. Coast of Huanghua, The Bohai SeaCytotoxicity (MDA-MB-231, MCF-7, MGC-803, HeLa, A549)[81]
Auxarthrols D (131) and F (132)Sporendonema caseiZhangzi Island, The Yellow SeaCytotoxicity (a few human cancer cells)[82]
Altersolanol B (133) Antibacterial (Mycobacterium phlei, Bacillus subtilis, Vibrio parahemolyticus and Pseudomonas aeruginosa)
9,10-Diolhinokiic acid (134)Talaromyces purpurogenusCoast of Qinghuangdao, The Bohai SeaCytotoxicity (HL-60 and A549)[83]
Roussoellol C (135) Cytotoxicity (MCF-7 and HL-60)
Dankasterone (136) Cytotoxicity (MCF-7 and HL-60)
19-Methoxy-19,20-dihydrophomacin C (137)Westerdykella dispersaGuangzhou, China, The South China SeaCytotoxicity (MCF-7, HepG2, A549, HT-29 and SGC-7901)[84]
Gymnastatin Z (138)
Phomacin B (139)
Cytochalasin P1 (140)Xylaria sp. SOF11 The South China SeaCytotoxicity (MCF-7, SF-268)[85]
19, 20-Epoxycytochalasin D (141)
Acremeremophilanes B–F (142146) and N (147)Acremonium sp. South part of The Atlantic OceanInhibition of NO production[88]
14-Hydroxy-cyclopeptine (148)Aspergillus sp. SCSIOW2 The South China SeaInhibition of NO production[89]
Dihydrobipolaroxin (149) [90]
Dihydrobipolaroxin B (150)
Dihydrobipolaroxin C (151)
Dihydrobipolaroxin D (152)
Asperteretal F (153)Aspergillus terreus Y10 Coastal area of Hainan, The South China SeaInhibition of TNF-α generation[91]
Asperversiamide G (154)Aspergillus versicolorThe South China SeaInhibition of iNO synthase activity[92]
6-[1-(2-aminobenzoyloxy)ethyl]-1-phenazinecarboxylic acid (155) Cystobasidium larynigsThe Indian OceanInhibition of NO production[93]
Saphenol (156)
Saphenic acid (157)
Phenazine-1-carboxylic acid (158)
6-(1-Hydroxyehtyl)phenazine-1-carboxylic acid (159)
6-Acetylphenazine-1-carboxylic acid (160)
Khusinol B (161)Graphostroma sp. MCCC 3A00421 The Atlantic OceanInhibition of NO production[94]
Emodacidamides A (162), C–E (163165)Penicillium sp. SCSIO sof101 Inhibition of interleukin-2 secretion[95]
7-Acetoxydehydroaustinol (166)Penicillium sp. F-5497 Busan, South Korea, Korean StraitSuppression of NO overproduction[96]
Chrysamide C (167)Penicillium chrysogenum SCSIO41001 The Indian OceanSuppression of interleukin-17 production[97]
Neuchromenin (168)Penicillium glabrum SF-7123 The Ross Sea, AntarcticaInhibition of NO and prostaglandin E2 production[98]
Myxotrichin C (169)
Deoxyfunicone (170)
Restricticin B (171)Penicillium janthinellumCu Lao Cham Island, The South China SeaSuppression of pro-inflammatory mediators production[99]
N-acetyl restricticin (172)
Piltunine E (173)Penicillium piltunense KMM 4668 Sakhalin Island, The Sea of OkhotskDownregulation of ROS production[100]
5′-Hydroxyasperentin (174)
Decreasing of NO production
Dehydrocurvularin (175)Penicillium sumatrenseThe Indian OceanInhibition of NO production[101]
Citrinin H1 (176)Penicillium sp. SF-5629 Ulgin, South Korea, The Sea of JapanInhibition of NO and prostaglandin E2 production[102]
Arthone C (177)Arthrinium sp. UJNMF0008 The South China SeaDPPH- and ABTS-radical scavenging[104]
6,9-Dibromoflavasperone (178)Aspergillus nigerSuncheon Bay, South Korea, Korean StraitDPPH-radical scavenging[105]
Flavasperone (179)
TMC-256A1 (180)
Fonsecin (181)
Aurasperone B (182)
Oxisterigmatocystin D (183)Aspergillus versicolorThe South China SeaAntioxidant activities in TEAC assay[106]
Oxisterigmatocystin C (184) Antioxidant activities in TEAC assay
Sterigmatocystine (185)
Dihydrosterigmatocystine (186)
Versicolorin B (187)
UCT1072M1 (188) Antioxidant activities in TEAC assay, Activation of Nrf2-regulated gene expression
Averantin (189)
Methylaverantin (190) Antioxidant activities in TEAC assay
Averythrin (191) Antioxidant activities in TEAC assay, Activation of Nrf2-regulated gene expression
Averufanin (192) Antioxidant activities in TEAC assay
Averufine (193)
Nidurufin (194) Antioxidant activities in TEAC assay, Activation of Nrf2-regulated gene expression
Cladosporin D (195)Cladosporium sp. SCSIO z015 Okinawa Trough, The East China SeaDPPH radical scavenging[107]
Eurotiumins A–C (196198)Eurotium sp. SCSIO F452 The South China SeaDPPH-radical scavenging[108]
Eurotinoids A–C (199204) [109]
(+)-Dihydrocryptoechinulin D (205) Cytotoxicity (SF-268, HepG2)
DPPH-radical scavenging
(-)-Dihydrocryptoechinulin D (206)
(+)-Euroticin B (207) Antioxidant activities[110]
(–)-Euroticin B (208)
Niveoglaucin A (209)Aspergillus niveoglaucusNha Trang Bay, The South China SeaSuppression of ROS hyperproduction,
Neuroprotective activity
[111]
Flavoglaucin (210) [111]
(+)-Cryptoechinuline B (211) [112]
(–)-Cryptoechinuline B (212)
Neoechinulin (213)
Neoechinulines B–C (214215)
Perylenequinone (216)Alternaria sp. NH-F6 The South China SeaInhibition of BRD4 protein [122]
Protuboxepin K (217)Aspergillus sp. BFM-0085 Tokyo Bay, Tokyo, JapanInhibition of (BMP)-induced alkaline phosphatase activity[123]
Protuboxepin A (218)
Flavipesolides A–C (219221)Aspergillus flavipes HN4-13 The Yellow SeaInhibition of α-glucosidase activity[124]
5-[(3,4-Dihydro-2,2-dimethyl-2H-1-benzopyran-6-yl)methyl]-3-
hydroxy-4-(4-hydroxyphenyl)-2(5H)furanone (222)
Aspernolide A (223)
Emodin (224)
Geodin hydrate (225)
Methyl dichloroasterrate (226)
Monomethylosoic acid (227)
Asperversin G (228)Aspergillus versicolorThe South China SeaInhibition of AChE activity[125]
7-Chlorofolipastatin (229)Aspergillus unguiSuruga Bay, JapanInhibition of SOAT1- and SOAT2-expressing[126]
Biscogniauxone (230)Biscogniauxia mediterraneaHerodotes Deep, The Mediterranean SeaInhibition of glycogen synthase kinase (GSK-3β) activity[127]
Cyclo-(L-Phe-L-Leu-L-Val-L-Leu-L-Leu) (231)
Preaustinoid A6 (232)Penicillium sp. SF-5497 Gijang-gun, Busan, South Korea, Korean StraitInhibition of PTP1B activity[128]
Berkeleyone C (233)
Butanolide A (234)Penicillium sp. S-1-18 Antarctica[129]
Austalide V (235)Penicillium rudallenseGa-geo Island, South Korea, The Yellow SeaInhibition of (RANKL)-induced osteoclast differentiation[130]
Austalide W (236)
Diorcinol J (237)Aspergillus sulphureus KMM 4640 (The Sea of Okhotsk) and Isaria felina KMM 4639 (The South China Sea) Hemolytic activity and cytotoxicity (Ehrlich carcinoma)[131]
Diorcinol B (238) Enhancing of Hsp70 expression
Terretonin H (239) Aspergillus ustus KMM 4664 The Sea of OkhotskInhibition of the ability of spermatozoa to fertilize egg-cells of the sea urchin Strongilocentrotus intermedius[132]
Terretonin I (240)
ent-Peniciherqueinone (241) Penicillium sp. Gagudo, South KoreaInduction of adipogenesis[133]
4-Hydroxysclerodin (242) Anti-angiogenetic and anti-inflammatory activities,
Inhibition of tube formation
(9R)-2,5,7-Trihydroxy-1,8,8,9-tetramethyl-5-(2-oxopropyl)-8,9-dihydro-3H-phenaleno[1,2-b]furan-3,4,6(3aH,5H)-trione (243) Inhibition of NO production
Isoherqueinone (244) Induction of adipogenesis
Spirograterpene A (245)Penicillium granulatum MCCC 3A00475 Antiallergic activity[134]
Stachybotrysin (246)Stachybotrys sp. KCB13F013 Wi Island, South Korea, The Yellow SeaInhibition of osteoclast differentiation[135]
Acronyms: SA—Staphylococcus aureus, MRSA—methicillin-resistant Staphylococcus aureus, E. coli—Escherichia coli, VRE—vancomycin-resistant Enterococcus faecalis, MDRSA—multidrug-resistant Staphylococcus aureus.

References

  1. D’Hondt, S.; Rutherford, S.; Spivack, A.J. Metabolic activity of subsurface life in deep-sea sediments. Science 2002, 295, 2067–2070. [Google Scholar] [CrossRef] [PubMed]
  2. Parkes, R.J.; Cragg, B.; Roussel, E.; Webster, G.; Weightman, A.; Sass, H. A review of prokaryotic populations and processes in sub-seafloor sediments, including biosphere:geosphere interactions. Mar. Geol. 2014, 352, 409–425. [Google Scholar] [CrossRef]
  3. Bulan, D.E.; Wilantho, A.; Tongsima, S.; Viyakarn, V.; Chavanich, S.; Somboonna, N. Microbial and Small Eukaryotes Associated With Reefs in the Upper Gulf of Thailand. Front. Mar. Sci. 2018, 5, 5. [Google Scholar] [CrossRef]
  4. Polinski, J.M.; Bucci, J.P.; Gasser, M.; Bodnar, A.G. Metabarcoding assessment of prokaryotic and eukaryotic taxa in sediments from Stellwagen Bank National Marine Sanctuary. Sci. Rep. 2019, 9, 1–8. [Google Scholar] [CrossRef] [Green Version]
  5. Martin-Pozas, T.; Gonzalez-Pimentel, J.L.; Jurado, V.; Cuezva, S.; Dominguez-Moñino, I.; Fernandez-Cortes, A.; Cañaveras, J.C.; Sanchez-Moral, S.; Saiz-Jimenez, C. Microbial Activity in Subterranean Ecosystems: Recent Advances. Appl. Sci. 2020, 10, 8130. [Google Scholar] [CrossRef]
  6. Shao, M.; Sun, C.; Liu, X.; Wang, X.; Li, W.; Wei, X.; Li, Q.; Ju, J. Upregulation of a marine fungal biosynthetic gene cluster by an endobacterial symbiont. Commun. Biol. 2020, 3, 1–11. [Google Scholar] [CrossRef] [PubMed]
  7. Bajpai, V.K. Antimicrobial secondary metabolites from marine fungi: A mini review. Indian J. Geo. Mar. Sci. 2016, 45, 1067–1075. [Google Scholar]
  8. Frisvad, J.C.; Smedsgaard, J.; Larsen, T.O.; Samson, R.A. Mycotoxins, drugs and other extrolites produced by species in Penicillium subgenus Penicillium. Stud. Mycol. 2004, 49, 201–241. [Google Scholar]
  9. Liu, S.; Su, M.; Song, S.J.; Jung, J.H. Marine-derived Penicillium species as producers of cytotoxic metabolites. Mar. Drugs 2017, 15, 329. [Google Scholar] [CrossRef] [Green Version]
  10. Rateb, M.E.M.; Ebel, R. Secondary metabolites of fungi from marine habitats. Nat. Prod. Rep. 2011, 28, 290–344. [Google Scholar] [CrossRef]
  11. Chen, G.; Wang, H.-F.; Pei, Y.-H. Secondary metabolites from marine-derived microorganisms. J. Asian Nat. Prod. Res. 2014, 16, 105–122. [Google Scholar] [CrossRef] [PubMed]
  12. Blunt, J.W.; Copp, B.R.; Keyzers, R.A.; Munro, M.H.G.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2015, 32, 116–211. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Liming, J.; Chunshan, Q.; Xiyan, H.; Shengdi, F. Potential pharmacological resources: Natural bioactive compounds from marine-derived fungi. Mar. Drugs 2016, 14, 76. [Google Scholar]
  14. Moghadamtousi, S.Z.; Nikzad, S.; Kadir, H.A.; Abubakar, S.; Zandi, K. Potential Antiviral Agents from Marine Fungi: An Overview. Mar. Drugs 2015, 13, 4520–4538. [Google Scholar] [CrossRef]
  15. Luo, M.; Zang, R.; Wang, X.; Chen, Z.; Song, X.; Ju, J.; Huang, H. Natural Hydroxamate-Containing Siderophore Acremonpeptides A-D and an Aluminum Complex of Acremonpeptide D from the Marine-Derived Acremonium persicinum SCSIO 115. J. Nat. Prod. 2019, 82, 2594–2600. [Google Scholar] [CrossRef]
  16. Liu, F.-A.; Lin, X.-P.; Zhou, X.-F.; Chen, M.; Huang, X.; Yang, B.; Tao, H. Xanthones and Quinolones Derivatives Produced by the Deep-Sea-Derived Fungus Penicillium sp. SCSIO Ind16F01. Molecules 2017, 22, 1999. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Niu, S.; Si, L.; Liu, D.; Zhou, A.; Zhang, Z.; Shao, Z.; Wang, S.; Zhang, L.; Zhou, D.; Lin, W. Spiromastilactones: A new class of influenza virus inhibitors from deep-sea fungus. Eur. J. Med. Chem. 2016, 108, 229–244. [Google Scholar] [CrossRef] [PubMed]
  18. Wang, C.; Tang, S.; Cao, S. Antimicrobial compounds from marine fungi. Phytochem. Rev. 2020, 1–33. [Google Scholar] [CrossRef]
  19. Xu, X.; Yang, H.; Xu, H.; Yin, L.; Chen, Z.; Shen, H. Diphenyl ethers from a marine-derived isolate of Aspergillus sp. CUGB-F046. Nat. Prod. Res. 2017, 32, 821–825. [Google Scholar] [CrossRef]
  20. Zhu, A.; Yang, M.-Y.; Zhang, Y.-H.; Shao, C.-L.; Wang, C.-Y.; Hu, L.-D.; Cao, F.; Zhu, H.-J. Absolute Configurations of 14,15-Hydroxylated Prenylxanthones from a Marine-Derived Aspergillus sp. Fungus by Chiroptical Methods. Sci. Rep. 2018, 8, 1–10. [Google Scholar] [CrossRef] [Green Version]
  21. Zhu, A.; Zhang, X.W.; Zhang, M.; Li, W.; Ma, Z.Y.; Zhu, H.J.; Cao, F. Aspergixanthones I–K, new anti-vibrio prenylxan-thones from the marine-derived fungus Aspergillus sp. ZA-01. Mar. Drugs 2018, 16, 312. [Google Scholar] [CrossRef] [Green Version]
  22. Hwang, J.Y.; Lee, J.H.; Park, S.C.; Lee, J.; Oh, D.C.; Oh, K.B.; Shin, J. New Peptides from The Marine-Derived Fungi Aspergillus allahabadii and Aspergillus ochraceopetaliformis. Mar. Drugs 2019, 17, 488. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Liu, Z.; Wang, Q.; Li, S.; Cui, H.; Sun, Z.; Chen, D.; Lu, Y.; Liu, H.; Zhang, W. Polypropionate Derivatives with Mycobacterium tuberculosis Protein Tyrosine Phosphatase B Inhibitory Activities from the Deep-Sea-Derived Fungus Aspergillus fischeri FS452. J. Nat. Prod. 2019, 82, 3440–3449. [Google Scholar] [CrossRef]
  24. Han, J.; Liu, M.; Jenkins, I.; Liu, X.; Zhang, L.; Quinn, R.J.; Feng, Y. Genome-Inspired Chemical Exploration of Marine Fungus Aspergillus fumigatus MF071. Mar. Drugs 2020, 18, 352. [Google Scholar] [CrossRef] [PubMed]
  25. Corral, P.; Esposito, F.P.; Tedesco, P.; Falco, A.; Tortorella, E.; Tartaglione, L.; Festa, C.; D’Auria, M.V.; Gnavi, G.; Varese, G.C.; et al. Identification of a Sorbicillinoid-Producing Aspergillus Strain with Antimicrobial Activity Against Staphylococcus aureus: A New Polyextremophilic Marine Fungus from Barents Sea. Mar. Biotechnol. 2018, 20, 502–511. [Google Scholar] [CrossRef] [PubMed]
  26. Hu, J.; Li, Z.; Gao, J.; He, H.; Dai, H.; Xia, X.; Liu, C.H.; Zhang, L.; Song, F. New Diketopiperazines from a Marine-Derived Fungus Strain Aspergillus versicolor MF180151. Mar. Drugs 2019, 17, 262. [Google Scholar] [CrossRef] [Green Version]
  27. Wang, W.; Chen, R.; Luo, Z.; Wang, W.; Chen, J. Antimicrobial activity and molecular docking studies of a novel anthraquinone from a marine-derived fungus Aspergillus versicolor. Nat. Prod. Res. 2018, 32, 558–563. [Google Scholar] [CrossRef]
  28. Zhang, D.; Yi, W.; Ge, H.; Zhang, Z.; Wu, B. A new antimicrobial indoloditerpene from a marine-sourced fungus aspergillus versicolor ZZ761. Nat. Prod. Res. 2019, 1–6. [Google Scholar] [CrossRef]
  29. Li, X.D.; Li, X.M.; Li, X.; Xu, G.M.; Liu, Y.; Wang, B.G. Aspewentins D-H, 20-Nor-isopimarane Derivatives from the Deep Sea Sediment-Derived Fungus Aspergillus wentii SD-310. J. Nat. Prod. 2016, 79, 1347–1353. [Google Scholar] [CrossRef]
  30. Fredimoses, M.; Zhou, X.-F.; Ai, W.; Tian, X.; Yang, B.; Lin, X.; Liu, J.; Liu, Y. Emerixanthone E, a new xanthone derivative from deep sea fungus Emericella sp SCSIO 05240. Nat. Prod. Res. 2019, 33, 2088–2094. [Google Scholar] [CrossRef]
  31. Inostroza, A.; Lara, L.; Paz, C.; Perez, A.; Galleguillos, F.; Hernandez, V.; Becerra, J.; González-Rocha, G.; Silva, M. Antibiotic activity of Emerimicin IV isolated from Emericellopsis minima from Talcahuano Bay, Chile. Nat. Prod. Res. 2017, 32, 1361–1364. [Google Scholar] [CrossRef]
  32. Wang, W.; Chen, R.; Luo, Z.; Wang, W.; Chen, J. Two new benzoate derivatives and one new phenylacetate derivative from a marine-derived fungus Engyodontium album. Nat. Prod. Res. 2016, 31, 758–764. [Google Scholar] [CrossRef]
  33. Wang, W.; Li, S.; Chen, Z.; Liao, Y. Secondary Metabolites Produced by the Deep-Sea-Derived Fungus Engyodontium album. Chem. Nat. Compd. 2017, 77, 1021–1226. [Google Scholar] [CrossRef]
  34. Niu, S.; Liu, D.; Shao, Z.; Proksch, P.; Lin, W. Eutypellazines N−S, new thiodiketopiperazines from a deep sea sediment derived fungus Eutypella sp. with anti-VRE activities. Tetrahedron Lett. 2017, 58, 3695–3699. [Google Scholar] [CrossRef]
  35. Liu, H.-X.; Zhang, L.; Chen, Y.; Sun, Z.-H.; Pan, Q.; Li, H.; Zhang, W.-M. Monoterpenes and sesquiterpenes from the marine sediment-derived fungus Eutypella scoparia FS46. J. Asian Nat. Prod. Res. 2016, 19, 145–151. [Google Scholar] [CrossRef] [PubMed]
  36. Nenkep, V.; Yun, K.; Son, B.W. Oxysporizoline, an antibacterial polycyclic quinazoline alkaloid from the marine-mudflat-derived fungus Fusarium oxysporum. J. Antibiot. 2016, 69, 709–711. [Google Scholar] [CrossRef] [PubMed]
  37. Lee, J.; Lee, J.; Kim, G.J.; Yang, I.; Wang, W.; Nam, J.-W.; Choi, H.; Nam, S.-J.; Kang, H. Mycousfurans A and B, Antibacterial Usnic Acid Congeners from the Fungus Mycosphaerella sp., Isolated from a Marine Sediment. Mar. Drugs 2019, 17, 422. [Google Scholar] [CrossRef] [Green Version]
  38. Le, H.M.T.; Do, Q.T.; Huong, D.T.M.; Thi, Q.V.; Nguyen, M.A.; Vu, T.H.T.; Dang, N.H.; Nguyen, T.D.T.; Tran, M.H.; Chau, V.M.; et al. Chemical Composition and Biological Activities of Metabolites from the Marine Fungi Penicillium sp. Isolated from Sediments of Co To Island, Vietnam. Molecules 2019, 24, 3830. [Google Scholar] [CrossRef] [Green Version]
  39. Song, X.; Tu, R.; Mei, X.; Wu, S.; Lan, B.; Zhang, L.; Luo, M.; Liu, J.; Luo, M. A mycophenolic acid derivative from the fungus Penicillium sp. SCSIO sof101. Nat. Prod. Res. 2019, 34, 1206–1212. [Google Scholar] [CrossRef]
  40. Kaleem, S.; Ge, H.; Yi, W.; Zhang, Z.; Wu, B. Isolation, structural elucidation, and antimicrobial evaluation of the me-tabolites from a marine-derived fungus Penicillium sp. ZZ1283. Nat. Prod. Res. 2019. [Google Scholar] [CrossRef]
  41. Pan, C.; Shi, Y.; Auckloo, B.N.; Chen, C.-T.A.; Chen, X.; Wu, X.; Wu, B. Four Verrucosidin Derivatives Isolated from the Hydrothermal Vent Sulfur-Derived Fungus Penicillium sp. Y-50-10. Chem. Nat. Compd. 2018, 54, 253–256. [Google Scholar] [CrossRef]
  42. Li, Y.-H.; Li, X.-M.; Li, X.; Yang, S.-Q.; Shi, X.-S.; Li, H.-L.; Wang, B.-G. Antibacterial Alkaloids and Polyketide Derivatives from the Deep Sea-Derived Fungus Penicillium cyclopium SD-413. Mar. Drugs 2020, 18, 553. [Google Scholar] [CrossRef] [PubMed]
  43. Chang, A.; Sun, S.; Li, L.; Dai, X.; Li, H.; He, Q.; Zhu, H. Tyrosol from marine Fungi, a novel Quorum sensing inhibitor against Chromobacterium violaceum and Pseudomonas aeruginosa. Bioorganic Chem. 2019, 91, 103140. [Google Scholar] [CrossRef] [PubMed]
  44. Guo, X.-C.; Xu, L.-L.; Yang, R.-Y.; Yang, M.-Y.; Hu, L.-D.; Zhu, H.-J.; Cao, F. Anti-Vibrio Indole-Diterpenoids and C-25 Epimeric Steroids From the Marine-Derived Fungus Penicillium janthinellum. Front. Chem. 2019, 7, 80. [Google Scholar] [CrossRef] [Green Version]
  45. Leutou, A.S.; Yun, K.; Son, B.W. New production of antibacterial polycyclic quinazoline alkaloid, thielaviazoline, from anthranilic acid by the marine-mudflat-derived fungus Thielavia sp. Nat. Prod. Sci. 2016, 22, 216–219. [Google Scholar] [CrossRef]
  46. Xu, D.; Zhang, X.; Shi, X.; Xian, P.-J.; Hong, L.; Tao, Y.-D.; Yang, X.-L. Two new cytochalasans from the marine sediment-derived fungus Westerdykella dispersa and their antibacterial activities. Phytochem. Lett. 2019, 32, 52–55. [Google Scholar] [CrossRef]
  47. Chokpaiboon, S.; Unagul, P.; Nithithanasilp, S.; Komwijit, S.; Somyong, W.; Ratiarpakul, T.; Isaka, M.; Bunyapaiboonsri, T. Salicylaldehyde and dihydroisobenzofuran derivatives from the marine fungus Zopfiella marina. Nat. Prod. Res. 2017, 32, 149–153. [Google Scholar] [CrossRef]
  48. Ding, L.; Xu, P.; Li, T.; Liao, X.; He, S.; Xu, S. Asperfurandiones A and B, two antifungal furandione analogs from a marine-derived fungus Aspergillus versicolor. Nat. Prod. Res. 2019, 33, 3404–3408. [Google Scholar] [CrossRef]
  49. Cao, F.; Yang, J.-K.; Liu, Y.-F.; Zhu, H.J.; Wang, C.-Y. Pleosporalone A, the first azaphilone characterized with aromatic A-ring from a marine-derived Pleosporales sp. fungus. Nat. Prod. Res. 2016, 30, 2448–2452. [Google Scholar] [CrossRef]
  50. Cao, F.; Meng, Z.-H.; Mu, X.; Yue, Y.-F.; Zhu, H.-J. Absolute Configuration of Bioactive Azaphilones from the Marine-Derived Fungus Pleosporales sp. CF09-1. J. Nat. Prod. 2019, 82, 386–392. [Google Scholar] [CrossRef] [PubMed]
  51. Cao, F.; Zhao, D.; Chen, X.-Y.; Liang, X.-D.; Li, W.; Zhu, H.J. Antifungal Drimane Sesquiterpenoids From a Marine-Derived Pleosporales sp. Fungus. Chem. Nat. Compd. 2017, 53, 1189–1191. [Google Scholar] [CrossRef]
  52. Xu, D.; Pang, X.J.; Zhao, T.; Xu, L.L.; Yang, X.L. New alkenylated tetrahydropyran derivatives from the marine sedi-ment-derived fungus Westerdykella dispersa and their bioactivities. Fitoterapia 2017, 122, 45–51. [Google Scholar] [CrossRef] [PubMed]
  53. Liang, X.-R.; Ma, X.-Y.; Ji, N.-Y. Trichosordarin A, a norditerpene glycoside from the marine-derived fungus Trichoderma harzianum R5. Nat. Prod. Res. 2019, 34, 2037–2042. [Google Scholar] [CrossRef] [PubMed]
  54. Global Burden of Disease 2019 Disease, Injury, and Impairment Summaries. Available online: http://www.healthdata.org/results/gbd_summaries/2019 (accessed on 25 December 2020).
  55. Stien, D. Marine Microbial Diversity as a Source of Bioactive Natural Products. Mar. Drugs 2020, 18, 215. [Google Scholar] [CrossRef] [PubMed]
  56. Deshmukh, S.K.; Prakash, V.; Ranjan, N. Marine Fungi: A Source of Potential Anticancer Compounds. Front. Microbiol. 2018, 8, 2536. [Google Scholar] [CrossRef]
  57. Yu, G.; Wang, Y.; Yu, R.; Feng, Y.; Wang, L.; Che, Q.; Gu, Q.; Li, D.; Li, J.; Zhu, T. Chetracins E and F, cytotoxic epipolythiodioxopiperazines from the marine-derived fungus Acrostalagmus luteoalbus HDN13-530. RSC Adv. 2018, 8, 53–58. [Google Scholar] [CrossRef] [Green Version]
  58. Wang, F.; Wang, F.; Sarotti, A.M.; Jiang, G.; Huguet-Tapia, J.C.; Zheng, S.L.; Wu, X.; Li, C.; Ding, Y.; Cao, S.; et al. Waikikiamides A–C: Complex Diketopiperazine Dimer and Diketopiperazine-Polyketide Hybrids from a Hawaiian Marine Fungal Strain Aspergillus sp. FM242. Org. Lett. 2020, 22, 4408–4412. [Google Scholar] [CrossRef]
  59. Liu, Y.-F.; Yue, Y.-F.; Feng, L.-X.; Zhu, H.-J.; Cao, F. Asperienes A–D, Bioactive Sesquiterpenes from the Marine-Derived Fungus Aspergillus flavus. Mar. Drugs 2019, 17, 550. [Google Scholar] [CrossRef] [Green Version]
  60. Yurchenko, A.N.; Trinh, P.T.H.; Girich, E.V.; Smetanina, O.F.; Rasin, A.B.; Popov, R.S.; Dyshlovoy, S.A.; Von Amsberg, G.; Menchinskaya, E.S.; Van, T.T.T.; et al. Biologically Active Metabolites from the Marine Sediment-Derived Fungus Aspergillus flocculosus. Mar. Drugs 2019, 17, 579. [Google Scholar] [CrossRef] [Green Version]
  61. Wang, Y.; Li, D.; Li, Z.; Sun, Y.-J.; Hua, H.; Liu, T.; Bai, J. Terpenoids from the Marine-Derived Fungus Aspergillus fumigatus YK-7. Molecules 2015, 21, 31. [Google Scholar] [CrossRef]
  62. Li, D.-H.; Han, T.; Guan, L.-P.; Bai, J.; Zhao, N.; Li, Z.-L.; Wu, X.; Hua, H. New naphthopyrones from marine-derived fungus Aspergillus niger 2HL-M-8 and their in vitro antiproliferative activity. Nat. Prod. Res. 2015, 30, 1116–1122. [Google Scholar] [CrossRef]
  63. Uchoa, P.K.S.; Pimenta, A.T.A.; Braz-Filho, R.; Oliveira, M.D.C.F.D.; Saraiva, N.N.; Rodrigues, B.S.F.; Pfenning, L.H.; Abreu, L.M.; Wilke, D.V.; Florêncio, K.G.D.; et al. New cytotoxic furan from the marine sediment-derived fungi Aspergillus niger. Nat. Prod. Res. 2017, 31, 2599–2603. [Google Scholar] [CrossRef]
  64. Afiyatullov, S.S.; Zhuravleva, O.I.; Antonov, A.S.; Berdyshev, D.V.; Pivkin, M.V.; Denisenko, V.A.; Popov, R.S.; Gerasimenko, A.V.; Von Amsberg, G.; Dyshlovoy, S.A.; et al. Prenylated indole alkaloids from co-culture of marine-derived fungi Aspergillus sulphureus and Isaria felina. J. Antibiot. 2018, 71, 846–853. [Google Scholar] [CrossRef]
  65. Li, X.D.; Li, X.; Li, X.M.; Xu, G.M.; Zhang, P.; Meng, L.H.; Wang, B.G. Tetranorlabdane Diterpenoids from the Deep Sea Sediment-Derived Fungus Aspergillus wentii SD-310. Planta Med. 2016, 82, 877–881. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Zhong, W.; Wang, J.; Wei, X.; Chen, Y.; Fu, T.; Xiang, Y.; Huang, X.; Tian, X.; Xiao, Z.; Zhang, W.; et al. Variecolortins A–C, Three Pairs of Spirocyclic Diketopiperazine Enantiomers from the Marine-Derived Fungus Eurotium sp. SCSIO F452. Org. Lett. 2018, 20, 4593–4596. [Google Scholar] [CrossRef] [PubMed]
  67. Liu, H.; Zhang, L.; Chen, Y.; Li, S.; Tan, G.; Sun, Z.; Pan, Q.; Ye, W.; Li, H.-H.; Zhang, W. Cytotoxic pimarane-type diterpenes from the marine sediment-derived fungus Eutypella sp. FS46. Nat. Prod. Res. 2016, 31, 404–410. [Google Scholar] [CrossRef] [PubMed]
  68. Zhang, J.; Chen, Y.; Liu, Z.; Guo, B.; Gao, X.; Liu, H.; Zhang, W. Cytotoxic Secondary Metabolites from a Sea-Derived Fungal Strain of Hypoxylon rubiginosum FS521. Chin. J. Org. Chem. 2020, 40, 1367. [Google Scholar] [CrossRef]
  69. Smetanina, O.F.; Yurchenko, A.N.; Girich, E.V.; Kalinovsky, A.I.; Khudyakova, Y.V.; Dyshlovoy, S.A.; Von Amsberg, G.; Yurchenko, E.A.; Afiyatullov, S.S. Unique prostate cancer-toxic polyketides from marine sediment-derived fungus Isaria felina. J. Antibiot. 2017, 70, 856–858. [Google Scholar] [CrossRef]
  70. Chen, L.; Zhu, T.; Zhu, G.; Liu, Y.; Wang, C.; Piyachaturawat, P.; Chairoungdua, A.; Zhu, W. Bioactive Natural Products from the Marine-Derived Penicillium brevicompactum OUCMDZ-4920. Chin. J. Org. Chem. 2017, 37, 2762. [Google Scholar] [CrossRef] [Green Version]
  71. Chen, L.; Zhao, Y.-Y.; Lan, R.-F.; Du, L.; Wang, B.-S.; Zhou, T.; Li, Y.-P.; Zhang, Q.-Q.; Ying, M.-G.; Zheng, Q.-H.; et al. Dicitrinone D, an antimitotic polyketide isolated from the marine-derived fungus Penicillium citrinum. Tetrahedron 2017, 73, 5900–5911. [Google Scholar] [CrossRef]
  72. Liu, C.-C.; Zhang, Z.-Z.; Feng, Y.-Y.; Gu, Q.-Q.; Li, D.; Zhu, T. Secondary metabolites from Antarctic marine-derived fungus Penicillium crustosum HDN153086. Nat. Prod. Res. 2018, 33, 414–419. [Google Scholar] [CrossRef] [PubMed]
  73. Xie, C.L.; Zhang, D.; Xia, J.M.; Hu, C.C.; Lin, T.; Lin, Y.K.; Wang, G.H.; Tian, W.J.; Li, Z.P.; Zhang, X.K.; et al. Steroids from the Deep-Sea-Derived Fungus Penicillium granulatum MCCC 3A00475 Induced Apoptosis via Retinoid X Receptor (RXR)-α Pathway. Mar. Drugs 2019, 17, 178. [Google Scholar] [CrossRef] [Green Version]
  74. Choi, B.-K.; Phan, T.H.T.; Hwang, S.; Oh, D.-C.; Kang, J.S.; Lee, H.-S.; Ngo, T.D.N.; Van Tran, T.T.; Shin, H.J. Resorcinosides A and B, Glycosylated Alkylresorcinols from a Marine-Derived Strain of the Fungus Penicillium janthinellum. J. Nat. Prod. 2019, 82, 3186–3190. [Google Scholar] [CrossRef] [PubMed]
  75. Du, L.; Zhang, Q.-Q.; Chen, L.; Bi, Y.-X.; Li, Y.; Li, X.-X.; Liu, Q.-Y.; Ying, M.-G.; Zheng, Q.-H. Secalonic Acids H and I, Two New Secondary Metabolites from the Marine-Derived Fungus Penicillium oxalicum. Heterocycles 2017, 94, 1766. [Google Scholar] [CrossRef] [Green Version]
  76. Liu, Q.-Y.; Zhang, Q.-Q.; Chen, L.; Lu, Z.-H.; Du, L.; Zheng, Q.-H. Secalonic Acids J–M, Four New Secondary Metabolites from the Marine-derived Fungus Penicillium oxalicum. Heterocycles 2019, 98, 955. [Google Scholar] [CrossRef] [Green Version]
  77. Wang, W.; Park, C.; Oh, E.; Sung, Y.; Lee, J.; Park, K.-H.; Kang, H. Benzophenone Compounds, from a Marine-Derived Strain of the Fungus Pestalotiopsis neglecta, Inhibit Proliferation of Pancreatic Cancer Cells by Targeting the MEK/ERK Pathway. J. Nat. Prod. 2019, 82, 3357–3365. [Google Scholar] [CrossRef]
  78. Xu, J.-L.; Liu, H.-X.; Chen, Y.-C.; Tan, H.-B.; Guo, H.; Xu, L.-Q.; Li, S.-N.; Huang, Z.-L.; Li, H.-H.; Gao, X.-X.; et al. Highly Substituted Benzophenone Aldehydes and Eremophilane Derivatives from the Deep-Sea Derived Fungus Phomopsis lithocarpus FS508. Mar. Drugs 2018, 16, 329. [Google Scholar] [CrossRef] [Green Version]
  79. Xu, J.; Liu, Z.; Chen, Y.; Tan, H.; Li, H.; Li, S.; Guo, H.; Huang, Z.; Gao, X.; Liu, H.; et al. Lithocarols A-F, six tenellone derivatives from the deep-sea derived fungus Phomopsis lithocarpus FS508. Bioorg. Chem. 2019, 87, 728–735. [Google Scholar] [CrossRef]
  80. Xu, J.; Tan, H.; Chen, Y.; Li, S.; Guo, H.; Huang, Z.; Li, H.; Gao, X.; Liu, H.; Zhang, W. Lithocarpinols A and B, a pair of diastereomeric antineoplastic tenellone derivatives from the deep-sea derived fungus Phomopsis lithocarpus FS508. Chin. Chem. Lett. 2019, 30, 439–442. [Google Scholar] [CrossRef]
  81. Cao, F.; Meng, Z.-H.; Wang, P.; Luo, D.-Q.; Zhu, H.-J. Dipleosporalones A and B, Dimeric Azaphilones from a Marine-Derived Pleosporales sp. Fungus. J. Nat. Prod. 2020, 83, 1283–1287. [Google Scholar] [CrossRef]
  82. Ge, X.; Sun, C.; Feng, Y.; Wang, L.; Peng, J.; Che, Q.; Gu, Q.-Q.; Zhu, T.; Li, D.; Zhang, G. Anthraquinone Derivatives from a Marine-Derived Fungus Sporendonema casei HDN16-802. Mar. Drugs 2019, 17, 334. [Google Scholar] [CrossRef] [Green Version]
  83. Wang, W.-J.; Wan, X.; Liu, J.; Wang, J.-P.; Zhu, H.; Chen, C.; Zhang, Y. Two New Terpenoids from Talaromyces purpurogenus. Mar. Drugs 2018, 16, 150. [Google Scholar] [CrossRef] [Green Version]
  84. Xu, D.; Luo, M.; Liu, F.; Wang, D.; Pang, X.; Zhao, T.; Xu, L.; Wu, X.; Xia, M.; Yang, X.-L. Cytochalasan and Tyrosine-Derived Alkaloids from the Marine Sediment-Derived Fungus Westerdykella dispersa and Their Bioactivities. Sci. Rep. 2017, 7, 11956. [Google Scholar] [CrossRef] [Green Version]
  85. Chen, Z.; Chen, Y.; Huang, H.; Yang, H.; Zhang, W.; Sun, Y.; Wen, J. Cytochalasin P1, a new cytochalasin from the marine-derived fungus Xylaria sp. SOF11. Z. Naturforsch. Sect. C J. Biosci. 2017, 72, 129–132. [Google Scholar] [CrossRef]
  86. Kishore, N.; Kumar, P.; Shanker, K.; Verma, A.K. Human disorders associated with inflammation and the evolving role of natural products to overcome. Eur. J. Med. Chem. 2019, 179, 272–309. [Google Scholar] [CrossRef] [PubMed]
  87. Xu, J.; Yi, M.; Ding, L.; He, S. A Review of Anti-Inflammatory Compounds from Marine Fungi, 2000–2018. Mar. Drugs 2019, 17, 636. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  88. Cheng, Z.; Zhao, J.; Liu, N.; Proksch, P.; Zhao, Z.; Lin, W. Eremophilane-Type Sesquiterpenoids from an Acremonium sp. Fungus Isolated from Deep-Sea Sediments. J. Nat. Prod. 2016, 79, 1035–1047. [Google Scholar] [CrossRef] [PubMed]
  89. Zhou, X.; Fang, P.; Tang, J.; Wu, Z.; Li, X.; Li, S.; Wang, Y.; Liu, G.; He, Z.; Gou, D.; et al. A novel cyclic dipeptide from deep marine-derived fungus Aspergillus sp. SCSIOW2. Nat. Prod. Res. 2016, 30, 52–57. [Google Scholar] [CrossRef] [PubMed]
  90. Wang, L.; Li, M.; Tang, J.; Li, X. Eremophilane sesquiterpenes from a deep marine-derived fungus, Aspergillus sp. SCSIOW2, cultivated in the presence of epigenetic modifying agents. Molecules 2016, 21, 473. [Google Scholar] [CrossRef] [Green Version]
  91. Yang, L.H.; Ou-Yang, H.; Yan, X.; Tang, B.W.; Fang, M.J.; Wu, Z.; Chen, J.W.; Qiu, Y.K. Open-ring butenolides from a marine-derived anti-neuroinflammatory fungus Aspergillus terreus Y10. Mar. Drugs 2018, 16, 428. [Google Scholar] [CrossRef] [Green Version]
  92. Li, H.; Sun, W.; Deng, M.; Zhou, Q.; Wang, J.; Liu, J.; Chen, C.; Qi, C.; Luo, Z.; Xue, Y.; et al. Asperversiamides, Linearly Fused Prenylated Indole Alkaloids from the Marine-Derived Fungus Aspergillus versicolor. J. Org. Chem. 2018, 83, 8483–8492. [Google Scholar] [CrossRef] [PubMed]
  93. Lee, H.S.; Kang, J.S.; Choi, B.K.; Lee, H.S.; Lee, Y.J.; Lee, J.; Shin, H.J. Phenazine Derivatives with Anti-Inflammatory Activity from the Deep-Sea Sediment-Derived Yeast-Like Fungus Cystobasidium laryngis IV17-028. Mar. Drugs 2019, 17, 482. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  94. Niu, S.; Xie, C.-L.; Zhong, T.; Xu, W.; Luo, Z.; Shao, Z.; Yang, X.-W. Sesquiterpenes from a deep-sea-derived fungus Graphostroma sp. MCCC 3A00421. Tetrahedron 2017, 73, 7267–7273. [Google Scholar] [CrossRef]
  95. Luo, M.; Cui, Z.; Huang, H.; Song, X.; Sun, A.; Dang, Y.; Lu, L.; Ju, J. Amino Acid Conjugated Anthraquinones from the Marine-Derived Fungus Penicillium sp. SCSIO sof101. J. Nat. Prod. 2017, 80, 1668–1673. [Google Scholar] [CrossRef] [PubMed]
  96. Park, J.-S.; Quang, T.H.; Yoon, C.-S.; Kim, H.J.; Sohn, J.H.; Oh, H.C. Furanoaustinol and 7-acetoxydehydroaustinol: New meroterpenoids from a marine-derived fungal strain Penicillium sp. SF-5497. J. Antibiot. 2018, 71, 557–563. [Google Scholar] [CrossRef] [PubMed]
  97. Chen, S.; Wang, J.; Lin, X.; Zhao, B.; Wei, X.; Li, G.; Kaliaperumal, K.; Liao, S.; Yang, B.; Zhou, X.-F.; et al. Chrysamides A–C, Three Dimeric Nitrophenyl trans-Epoxyamides Produced by the Deep-Sea-Derived Fungus Penicillium chrysogenum SCSIO41001. Org. Lett. 2016, 18, 3650–3653. [Google Scholar] [CrossRef]
  98. Ha, T.M.; Kim, D.-C.; Sohn, J.H.; Yim, J.H.; Oh, H.C. Anti-Inflammatory and Protein Tyrosine Phosphatase 1B Inhibitory Metabolites from the Antarctic Marine-Derived Fungal Strain Penicillium glabrum SF-7123. Mar. Drugs 2020, 18, 247. [Google Scholar] [CrossRef]
  99. Choi, B.-K.; Jo, S.-H.; Choi, D.-K.; Trinh, P.T.H.; Lee, H.-S.; Van Anh, C.; Van, T.T.T.; Shin, H.J. Anti-Neuroinflammatory Agent, Restricticin B, from the Marine-Derived Fungus Penicillium janthinellum and Its Inhibitory Activity on the NO Production in BV-2 Microglia Cells. Mar. Drugs 2020, 18, 465. [Google Scholar] [CrossRef]
  100. Afiyatullov, S.S.; Zhuravleva, O.I.; Antonov, A.S.; Leshchenko, E.V.; Pivkin, M.V.; Khudyakova, Y.V.; Denisenko, V.A.; Pislyagin, E.; Kim, N.; Berdyshev, D.V.; et al. Piltunines A–F from the Marine-Derived Fungus Penicillium piltunense KMM 4668. Mar. Drugs 2019, 17, 647. [Google Scholar] [CrossRef] [Green Version]
  101. Wu, Y.-H.; Zhang, Z.-H.; Zhong, Y.; Huang, J.-J.; Li, X.-X.; Jiang, J.-Y.; Deng, Y.-Y.; Zhang, L.-H.; He, F. Sumalactones A–D, four new curvularin-type macrolides from a marine deep sea fungus Penicillium Sumatrense. RSC Adv. 2017, 7, 40015–40019. [Google Scholar] [CrossRef] [Green Version]
  102. Ngan, N.T.T.; Quang, T.H.; Kim, K.-W.; Kim, H.J.; Sohn, J.H.; Kang, D.G.; Lee, H.S.; Kim, Y.-C.; Oh, H. Anti-inflammatory effects of secondary metabolites isolated from the marine-derived fungal strain Penicillium sp. SF-5629. Arch. Pharmacal Res. 2017, 40, 328–337. [Google Scholar] [CrossRef] [PubMed]
  103. Pisoschi, A.M.; Pop, A.; Iordache, F.; Stanca, L.; Predoi, G.; Serban, A.I. Oxidative stress mitigation by antioxidants–An overview on their chemistry and influences on health status. Eur. J. Med. Chem. 2021, 209, 112891. [Google Scholar] [CrossRef] [PubMed]
  104. Bao, J.; He, F.; Yu, J.-H.; Zhai, H.; Cheng, Z.-Q.; Jiang, C.-S.; Zhang, Y.; Zhang, Y.; Zhang, X.; Chen, G.-Y.; et al. New Chromones from a Marine-Derived Fungus, Arthrinium sp., and Their Biological Activity. Molecules 2018, 23, 1982. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  105. Leutou, A.S.; Yun, K.; Son, B.W. Induced production of 6,9-dibromoflavasperone, a new radical scavenging naphthopy-ranone in the marine-mudflat-derived fungus Aspergillus niger. Arch. Pharm. Res. 2016, 39, 806–810. [Google Scholar] [CrossRef] [PubMed]
  106. Wu, Z.-H.; Liu, D.; Xu, Y.; Chen, J.-L.; Lin, W. Antioxidant xanthones and anthraquinones isolated from a marine-derived fungus Aspergillus versicolor. Chin. J. Nat. Med. 2018, 16, 219–224. [Google Scholar] [CrossRef]
  107. Amin, M.; Zhang, X.-Y.; Xu, X.-Y.; Qi, S.-H. New citrinin derivatives from the deep-sea-derived fungus Cladosporium sp. SCSIO z015. Nat. Prod. Res. 2019, 34, 1219–1226. [Google Scholar] [CrossRef]
  108. Zhong, W.-M.; Wang, J.; Shi, X.-F.; Wei, X.; Chen, Y.; Zeng, Q.; Xiang, Y.; Chen, X.-Y.; Tian, X.; Xiao, Z.-H.; et al. Eurotiumins A–E, Five New Alkaloids from the Marine-Derived Fungus Eurotium sp. SCSIO F452. Mar. Drugs 2018, 16, 136. [Google Scholar] [CrossRef] [Green Version]
  109. Zhong, W.; Wang, J.; Wei, X.; Fu, T.; Chen, Y.; Zeng, Q.; Huang, Z.; Huang, X.; Zhang, W.; Zhang, S.; et al. Three Pairs of New Spirocyclic Alkaloid Enantiomers From the Marine-Derived Fungus Eurotium sp. SCSIO F452. Front. Chem. 2019, 7, 350. [Google Scholar] [CrossRef] [PubMed]
  110. Zhong, W.-M.; Chen, Y.; Mai, Z.; Wei, X.; Wang, J.; Zeng, Q.; Chen, X.; Tian, X.; Zhang, W.-M.; Wang, F.; et al. Euroticins A and B, Two Pairs of Highly Constructed Salicylaldehyde Derivative Enantiomers from a Marine-Derived Fungus Eurotium sp. SCSIO F452. J. Org. Chem. 2020, 85, 12754–12759. [Google Scholar] [CrossRef]
  111. Smetanina, O.F.; Yurchenko, A.N.; Girich, E.V.; Trinh, P.T.H.; Antonov, A.S.; Dyshlovoy, S.A.; Von Amsberg, G.; Kim, N.; Chingizova, E.; Pislyagin, E.; et al. Biologically Active Echinulin-Related Indolediketopiperazines from the Marine Sediment-Derived Fungus Aspergillus niveoglaucus. Molecules 2019, 25, 61. [Google Scholar] [CrossRef] [Green Version]
  112. Yurchenko, A.N.; Smetanina, O.F.; Girich, E.V.; Phan, T.T.H.; Ngo, N.T.D.; Zhuravleva, O.I.; Rasin, A.B.; Dyshlovoy, S.A.; Menchinskaya, E.S.; Pislyagin, E.A.; et al. Auroglaucin-related neuroprotective compounds from Vietnamese marine sediment-derived fungus Aspergillus niveoglaucus. Nat. Prod. Res. 2020, 34, 2589–2594. [Google Scholar] [CrossRef]
  113. Liang, D.; Yu, Y.; Ma, Z. Novel strategies targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery. Eur. J. Med. Chem. 2020, 200, 112426. [Google Scholar] [CrossRef]
  114. He, R.; Du, S.; Lei, T.; Xie, X.; Wang, Y. Glycogen synthase kinase 3 beta in tumorigenesis and oncotherapy. Oncol. Rep. 2020, 44, 2373–2385. [Google Scholar] [CrossRef]
  115. Rana, A.K.; Rahmatkar, S.N.; Kumar, A.; Singh, D. Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Cytokine Growth Factor Rev. 2020. [Google Scholar] [CrossRef]
  116. Usman, B.; Sharma, N.; Satija, S.; Mehta, M.; Vyas, M.; Khatik, G.L.; Khurana, N.; Hansbro, P.M.; Williams, K.A.; Dua, K. Recent Developments in Alpha-Glucosidase Inhibitors for Management of Type-2 Diabetes: An Update. Curr. Pharm. Des. 2019, 25, 2510–2525. [Google Scholar] [CrossRef]
  117. Ezzat, S.M.; El Bishbishy, M.H.; Habtemariam, S.; Salehi, B.; Sharifi-Rad, M.; Martins, N.; Sharifi-Rad, J. Looking at Marine-Derived Bioactive Molecules as Upcoming Anti-Diabetic Agents: A Special Emphasis on PTP1B Inhibitors. Molecules 2018, 23, 28. [Google Scholar] [CrossRef] [Green Version]
  118. Saxena, M.; Dubey, R. Target Enzyme in Alzheimer’s Disease: Acetylcholinesterase Inhibitors. Curr. Top. Med. Chem. 2019, 19, 264–275. [Google Scholar] [CrossRef]
  119. Guan, C.; Niu, Y.; Chen, S.-C.; Kang, Y.; Wu, J.-X.; Nishi, K.; Chang, C.C.Y.; Chang, T.-Y.; Luo, T.; Chen, L. Structural insights into the inhibition mechanism of human sterol O-acyltransferase 1 by a competitive inhibitor. Nat. Commun. 2020, 11, 1–11. [Google Scholar] [CrossRef] [PubMed]
  120. Yun, C.W.; Kim, H.J.; Lim, J.H.; Lee, S.H. Heat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy. Cells 2019, 9, 60. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  121. Tukaj, S. Heat Shock Protein 70 as a Double Agent Acting Inside and Outside the Cell: Insights into Autoimmunity. Int. J. Mol. Sci. 2020, 21, 5298. [Google Scholar] [CrossRef] [PubMed]
  122. Ding, H.; Zhang, D.; Zhou, B.; Ma, Z. Inhibitors of BRD4 Protein from a Marine-Derived Fungus Alternaria sp. NH-F6. Mar. Drugs 2017, 15, 76. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  123. Ohte, S.; Shiokawa, T.; Koyama, N.; Katagiri, T.; Imada, C.; Tomoda, H. A new diketopiperazine-like inhibitor of bone morphogenetic protein-induced osteoblastic differentiation produced by marine-derived Aspergillus sp. BFM-0085. J. Antibiot. 2020, 73, 554–558. [Google Scholar] [CrossRef] [PubMed]
  124. Wang, C.; Guo, L.; Hao, J.; Wang, L.; Zhu, W. α-Glucosidase Inhibitors from the Marine-Derived Fungus Aspergillus flavipes HN4-13. J. Nat. Prod. 2016, 79, 2977–2981. [Google Scholar] [CrossRef]
  125. Li, H.; Sun, W.; Deng, M.; Qi, C.; Chen, C.; Zhu, H.; Luo, Z.; Wang, J.; Xue, Y.; Zhang, Y. Asperversins A and B, two novel meroterpenoids with an unusual 5/6/6/6 ring from the marine-derived fungus Aspergillus versicolor. Mar. Drugs 2018, 16, 177. [Google Scholar] [CrossRef] [Green Version]
  126. Uchida, R.; Nakajyo, K.; Kobayashi, K.; Ohshiro, T.; Terahara, T.; Imada, C.; Tomoda, H. 7-Chlorofolipastatin, an inhibitor of sterol O-acyltransferase, produced by marine-derived Aspergillus ungui NKH-007. J. Antibiot. 2016, 69, 647–651. [Google Scholar] [CrossRef] [PubMed]
  127. Wu, B.; Wiese, J.; Schmaljohann, R.; Imhoff, J.F. Biscogniauxone, a New Isopyrrolonaphthoquinone Compound from the Fungus Biscogniauxia mediterranea Isolated from Deep-Sea Sediments. Mar. Drugs 2016, 14, 204. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  128. Park, J.-S.; Quang, T.H.; Ngan, N.T.T.; Sohn, J.H.; Oh, H. New preaustinoids from a marine-derived fungal strain Penicillium sp. SF-5497 and their inhibitory effects against PTP1B activity. J. Antibiot. 2019, 72, 629–633. [Google Scholar] [CrossRef] [PubMed]
  129. Zhou, Y.; Li, Y.H.; Yu, H.B.; Liu, X.Y.; Lu, X.L.; Jiao, B.H. Furanone derivative and sesquiterpene from Antarctic marine-derived fungus Penicillium sp. S-1-18. J. Asian Nat. Prod. Res. 2018, 20, 1108–1115. [Google Scholar] [CrossRef]
  130. Wang, W.; Lee, J.; Kim, K.-J.; Sung, Y.; Park, K.-H.; Oh, E.; Park, C.; Son, Y.-J.; Kang, H. Austalides, osteoclast differentiation inhibitors from a marine-derived strain of the fungus Penicillium rudallense. J. Nat. Prod. 2019, 82, 3083–3088. [Google Scholar] [CrossRef]
  131. Zhuravleva, O.I.; Kirichuk, N.N.; Denisenko, V.A.; Dmitrenok, P.S.; Yurchenko, E.A.; Min′ko, E.M.; Ivanets, E.V.; Afiyatullov, S.S. New Diorcinol J Produced by Co-Cultivation of Marine Fungi Aspergillus sulphureus and Isaria felina. Chem. Nat. Compd. 2016, 52, 227–230. [Google Scholar] [CrossRef]
  132. Oleinikova, G.K.; Denisenko, V.A.; Berdyshev, D.V.; Pushilin, M.A.; Kirichuk, N.N.; Menzorova, N.I.; Kuzmich, A.S.; Yurchenko, E.A.; Zhuravleva, O.I.; Afiyatullov, S.S. Two new sesterterpenoids, terretonins H and I, from the marine-derived fungus Aspergillus ustus. Phytochem. Lett. 2016, 17, 135–139. [Google Scholar] [CrossRef]
  133. Park, S.C.; Julianti, E.; Ahn, S.; Kim, D.; Lee, S.K.; Noh, M.; Oh, D.-C.; Oh, K.-B.; Shin, A.J.; Shin, J. Phenalenones from a Marine-Derived Fungus Penicillium sp. Mar. Drugs 2019, 17, 176. [Google Scholar] [CrossRef] [Green Version]
  134. Niu, S.; Fan, Z.W.; Xie, C.L.; Liu, Q.; Luo, Z.H.; Liu, G.; Yang, X.W. Spirograterpene A, a Tetracyclic Spiro-Diterpene with a Fused 5/5/5/5 Ring System from the Deep-Sea-Derived Fungus Penicillium granulatum MCCC 3A00475. J. Nat. Prod. 2017, 80, 2174–2177. [Google Scholar] [CrossRef]
  135. Kim, J.W.; Ko, S.-K.; Kim, H.-M.; Kim, G.-H.; Son, S.; Kim, G.S.; Hwang, G.J.; Jeon, E.S.; Shin, K.-S.; Ryoo, I.-J.; et al. Stachybotrysin, an Osteoclast Differentiation Inhibitor from the Marine-Derived Fungus Stachybotrys sp. KCB13F013. J. Nat. Prod. 2016, 79, 2703–2708. [Google Scholar] [CrossRef] [PubMed]
  136. Ravishankar, J.P.; Muruganandam, V.; Suryanarayanan, T.S. Isolation and Characterization of Melanin from a Marine Fungus. Bot. Mar. 1995, 38, 413–416. [Google Scholar] [CrossRef]
  137. Ravishankar, J.P.; Suryanarayanan, T.S.; Muruganandam, V. Strategies for osmoregulation in the marine fungus Cirrenalia pygmea Kohl. (Hyphomycetes). Indian J. Mar. Sci. 2006, 35, 351–358. [Google Scholar]
  138. Girich, E.V.; Yurchenko, A.N.; Smetanina, O.F.; Trinh, P.T.; Ngoc, N.T.; Pivkin, M.V.; Popov, R.S.; Pislyagin, E.A.; Menchinskaya, E.S.; Chingizova, E.A.; et al. Neuroprotective Metabolites from Vietnamese Marine Derived Fungi of Aspergillus and Penicillium Genera. Mar. Drugs 2020, 18, 608. [Google Scholar] [CrossRef]
  139. Ao, J.; Bandyopadhyay, S.; Free, S.J. Characterization of the Neurospora crassa DHN melanin biosynthetic pathway in developing ascospores and peridium cells. Fungal Biol. 2019, 123, 1–9. [Google Scholar] [CrossRef]
  140. Mayer, K.M.; Ford, J.; MacPherson, G.R.; Padgett, D.; Volkmann-Kohlmeyer, B.; Kohlmeyer, J.; Murphy, C.; Douglas, S.E.; Wright, J.M.; Wright, J.L. Exploring the diversity of marine-derived fungal polyketide synthases. Can. J. Microbiol. 2007, 53, 291–302. [Google Scholar] [CrossRef]
  141. Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics. Available online: https://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/ (accessed on 25 December 2020).
  142. Plinabulin, a synthetic derivative of phenylahistine (from algicolous Aspergillus ustus)- Phase II and III of clinical trials in complex therapy of various cancers. Available online: https://www.clinicaltrials.gov (accessed on 25 December 2020).
Figure 1. The antiviral metabolites of marine sediment-derived fungi.
Figure 1. The antiviral metabolites of marine sediment-derived fungi.
Marinedrugs 19 00088 g001
Figure 2. The antibacterial metabolites (720) of marine sediment-derived fungi.
Figure 2. The antibacterial metabolites (720) of marine sediment-derived fungi.
Marinedrugs 19 00088 g002
Figure 3. The antibacterial metabolites (2136) of marine sediment-derived fungi.
Figure 3. The antibacterial metabolites (2136) of marine sediment-derived fungi.
Marinedrugs 19 00088 g003
Figure 4. The antibacterial metabolites (3745) of marine sediment-derived fungi.
Figure 4. The antibacterial metabolites (3745) of marine sediment-derived fungi.
Marinedrugs 19 00088 g004
Figure 5. The antibacterial metabolites (4666) of marine sediment-derived fungi.
Figure 5. The antibacterial metabolites (4666) of marine sediment-derived fungi.
Marinedrugs 19 00088 g005
Figure 6. The antifungal metabolites of marine sediment-derived fungi.
Figure 6. The antifungal metabolites of marine sediment-derived fungi.
Marinedrugs 19 00088 g006
Figure 7. The plankton-toxic metabolites of marine sediment-derived fungi.
Figure 7. The plankton-toxic metabolites of marine sediment-derived fungi.
Marinedrugs 19 00088 g007
Figure 8. The cytotoxic metabolites (8192) of marine sediment-derived fungi.
Figure 8. The cytotoxic metabolites (8192) of marine sediment-derived fungi.
Marinedrugs 19 00088 g008
Figure 9. The cytotoxic metabolites (93104) of marine sediment-derived fungi.
Figure 9. The cytotoxic metabolites (93104) of marine sediment-derived fungi.
Marinedrugs 19 00088 g009
Figure 10. The cytotoxic metabolites (105112) of marine sediment-derived fungi.
Figure 10. The cytotoxic metabolites (105112) of marine sediment-derived fungi.
Marinedrugs 19 00088 g010
Figure 11. The cytotoxic metabolites (113128) of marine sediment-derived fungi.
Figure 11. The cytotoxic metabolites (113128) of marine sediment-derived fungi.
Marinedrugs 19 00088 g011
Figure 12. The cytotoxic metabolites (129141) of marine sediment-derived fungi.
Figure 12. The cytotoxic metabolites (129141) of marine sediment-derived fungi.
Marinedrugs 19 00088 g012
Figure 13. The anti-inflammatory metabolites (142153) of marine sediment-derived fungi.
Figure 13. The anti-inflammatory metabolites (142153) of marine sediment-derived fungi.
Marinedrugs 19 00088 g013
Figure 14. The anti-inflammatory metabolites (154167) of marine sediment-derived fungi.
Figure 14. The anti-inflammatory metabolites (154167) of marine sediment-derived fungi.
Marinedrugs 19 00088 g014
Figure 15. The anti-inflammatory metabolites (168176) of marine sediment-derived fungi.
Figure 15. The anti-inflammatory metabolites (168176) of marine sediment-derived fungi.
Marinedrugs 19 00088 g015
Figure 16. The antioxidant metabolites (177182) of marine sediment-derived fungi.
Figure 16. The antioxidant metabolites (177182) of marine sediment-derived fungi.
Marinedrugs 19 00088 g016
Figure 17. The antioxidant metabolites (183208) of marine sediment-derived fungi.
Figure 17. The antioxidant metabolites (183208) of marine sediment-derived fungi.
Marinedrugs 19 00088 g017
Figure 18. The neuroprotective metabolites of marine sediment-derived fungi.
Figure 18. The neuroprotective metabolites of marine sediment-derived fungi.
Marinedrugs 19 00088 g018
Figure 19. The metabolites (215227) of marine sediment-derived fungi with influence on protein activity and expression.
Figure 19. The metabolites (215227) of marine sediment-derived fungi with influence on protein activity and expression.
Marinedrugs 19 00088 g019
Figure 20. The metabolites (228238) of marine sediment-derived fungi with influence on protein activity and expression.
Figure 20. The metabolites (228238) of marine sediment-derived fungi with influence on protein activity and expression.
Marinedrugs 19 00088 g020
Figure 21. The metabolites of marine sediment-derived fungi with other activities.
Figure 21. The metabolites of marine sediment-derived fungi with other activities.
Marinedrugs 19 00088 g021
Figure 22. Distribution of bioactive metabolites by (a) structural types and (b) types of activity.
Figure 22. Distribution of bioactive metabolites by (a) structural types and (b) types of activity.
Marinedrugs 19 00088 g022
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Yurchenko, A.N.; Girich, E.V.; Yurchenko, E.A. Metabolites of Marine Sediment-Derived Fungi: Actual Trends of Biological Activity Studies. Mar. Drugs 2021, 19, 88. https://doi.org/10.3390/md19020088

AMA Style

Yurchenko AN, Girich EV, Yurchenko EA. Metabolites of Marine Sediment-Derived Fungi: Actual Trends of Biological Activity Studies. Marine Drugs. 2021; 19(2):88. https://doi.org/10.3390/md19020088

Chicago/Turabian Style

Yurchenko, Anton N., Elena V. Girich, and Ekaterina A. Yurchenko. 2021. "Metabolites of Marine Sediment-Derived Fungi: Actual Trends of Biological Activity Studies" Marine Drugs 19, no. 2: 88. https://doi.org/10.3390/md19020088

APA Style

Yurchenko, A. N., Girich, E. V., & Yurchenko, E. A. (2021). Metabolites of Marine Sediment-Derived Fungi: Actual Trends of Biological Activity Studies. Marine Drugs, 19(2), 88. https://doi.org/10.3390/md19020088

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop